Wilson's disease: analysis of the first described cohort of native Mexican patients (English)
- New search for: Olivera-Martinez, M. A.
- New search for: Torre-Delgadillo, A.
- New search for: Zepeda-Gomez, S.
- New search for: Olivera-Martinez, M. A.
- New search for: Torre-Delgadillo, A.
- New search for: Zepeda-Gomez, S.
In:
JOURNAL OF HEPATOLOGY
;
36
;
274
;
2002
-
ISSN:
- Article (Journal) / Print
-
Title:Wilson's disease: analysis of the first described cohort of native Mexican patients
-
Contributors:
-
Published in:JOURNAL OF HEPATOLOGY ; 36 ; 274
-
Publisher:
- New search for: ELSEVIER SCIENCE
-
Publication date:2002-01-01
-
Size:274 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.3623
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.3623 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 36
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
The second year in BarcelonaRodes, J. et al. | 2002
- 3
-
Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV doseHadziyannis, S. J. / Cheinquer, H. / Morgan, T. / Diago, M. / Jensen, D. M. / Sette Jr, H. / Ramadori, G. / Bodenheimer, H. C. / Marcellin, P. / Lee, S. D. et al. | 2002
- 3
-
Hepatitis A virus superinfection suppresses hepatitis C virus replication and may lead to spontaneous HCV clearanceWedemeyer, H. / Tillmann, H. L. / Cornberg, M. / Tegtmeyer, B. / Manns, M. P. et al. | 2002
- 3
-
The Bridge - January 2002Reichen, J. et al. | 2002
- 3
-
Triple therapy with amantadine sulphate plus ribavirin and interferon-alpha in previously untreated patients with chronic hepatitis C: results of a double-blind, placebo-controlled trialBerg, T. / Kronenberger, B. / Hinrichsen, H. / Gerlach, T. / Buggisch, P. / Spengler, U. / Goeser, T. / Pape, G. / Hopf, U. / Zeuzem, S. et al. | 2002
- 4
-
Development of a quantitative assay for hepatic HBV ccc DNA levels in patients with chronic hepatitis BWerle, B. / Wursthorn, K. / Petersen, J. / Bowden, S. / Locarnini, S. / James, C. / Brosgart, C. / Xiong, S. / Delaney, W. / Gibbs, C. et al. | 2002
- 4
-
GS-98-438 a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for presumed precore mutant chronic hepatitis B: 48 week resultsHadziyannis, S. / Tassopolous, N. / Heathcote, E. / Chang, T. T. / Kitis, G. / Rizzetto, T. / Marcellin, P. / Lim, S. G. / Wulfsohn, M. / Wollman, M. et al. | 2002
- 4
-
Sperber I. Secretion of organic anions in the formation of urine and bile[Pharmacol. Rev. 1959;11:109-134]Boyer, J. L. et al. | 2002
- 4
-
Localisation of PKR and HCV-NS5A in living cells using fusion proteins with different mutants of GFPRealdon, S. / Gerotto, M. / Dal Pero, F. / Mongillo, M. / Zaccolo, M. / Alberti, A. et al. | 2002
- 5
-
CO-immunization with FLT3-L, a dendritic cell growth and stimulating factor, enhances humoral and cellular immune responses after genetic immunization against hepatitis C virus in miceEncke, J. / Bernardin, J. / Buidoso, R. / Stremmel, W. et al. | 2002
- 5
-
Hepatitis C virus NS3 serine protease variability and evolution are strongly constrained by the need for structural and functional conservationSoler, M. / Penin, F. / Ray, S. / Dhumeaux, D. / Pawlotsky, J. M. et al. | 2002
- 5
-
The expression of the transmembrane domains of HCV E1 protein induce cell deathCiccaglione, A. R. / Marcantonio, C. / Costantino, A. / Tritarelli, E. / Cammarata, C. / Equestre, M. / Rapicetta, M. et al. | 2002
- 6
-
Adefovir dipivoxil (ADV) alone and in combination with lamivudine (LAM) suppresses LAM-resistant hepatitis B virus (HBV) replication: 16 week interim analysisPeters, M. / Hann, H. W. / Martin, P. / Heathcote, E. / Buggisch, P. / Moorat, A. E. / Sullivan, M. / Kleber, K. / Ebrahimi, R. / Xiong, S. et al. | 2002
- 6
-
Identification of a hepatic protein which interacts with the IP3 receptor and regulates calcium signalsMagnino, F. / Schmidt, K. / Cassio, D. / Luethi, M. / Ziemiecki, A. / Dufour, J. F. et al. | 2002
- 6
-
The SLC11A3 gene, encoding for a main iron export protein, is controlled posttranscriptionally by ironLymboussaki, A. / Pignatti, E. / Montosi, G. / Garuti, C. / Pietrangelo, A. / Haile, D. et al. | 2002
- 6
-
Estradiol 17-glucuronide (E217G)-induced internalization of the canalicular bile salt export pump, Bsep, in the rat: its role in E217G-induced cholestasis and its prevention by dibutyryl cyclic AMP (DB-cAMP)Crocenzi, F. A. / Veggi, L. M. / Cao, J. / Vore, M. / Coleman, R. / Mottino, A. D. / Roma, M. G. et al. | 2002
- 7
-
Hepatitis B virus-specific T-cell reactivity during adefovir dipivoxil (ADV) treatment: a multicentre, controlled studyCooksley, H. / Chokshi, S. / Wedemeyer, H. / Andreone, P. / Gilson, R. / Warnes, T. / Paganin, S. / Zoulim, F. / Jain, A. / James, C. et al. | 2002
- 7
-
Loss of lamivudine resistance mutations after patients switched to adefovir dipivoxil therapyWestland, C. / Gibbs, C. / Miller, M. / Sullivan, M. / Fry, J. / Brosgart, C. / Wulfsohn, M. / Xiong, S. et al. | 2002
- 7
-
Thirty years follow-up of chronic asymptomatic HBsAg carriers: importance of occult infectionsManno, M. / Grottola, A. / Ferretti, I. / Colantoni, A. / De Maria, N. / Giannini, F. / Vecchi, C. / De Palma, M. / Manenti, F. / Villa, E. et al. | 2002
- 8
-
C4A dificiencies show a strong independent association with HBSAG vaccination failureHoehler, T. / Stradmaann-Bellinghausen, B. / Starke, R. / Sanger, R. / Victor, A. / Rittner, C. / Schneider, P. et al. | 2002
- 8
-
Histological improvement in HBeAg positive chronic hepatitis B patients treated with adefovir dipivoxilMarcellin, P. / Goodman, Z. / Chang, T. T. / Lim, S. G. / Tong, M. / Sievert, W. / Shiffman, M. / Jeffers, L. / Wulfsohn, M. / Fallis, R. et al. | 2002
- 8
-
Evidence for the efficacy of peginterferon alfa-2a (40 KD) (PEGASYS) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factorsCooksley, W. G. / Piratvisuth, T. / Wang, Y. J. / Mahachai, V. / Chao, Y. C. / Tanwandee, T. / Chutaputti, A. / Chang, W. Y. / Zahm, F. E. / Pluck, N. et al. | 2002
- 8
-
Human leukocyte antigen Class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosisStone, J. / Wade, J. A. / Cauch-Dudek, K. / Ng, C. / Lindor, K. D. / Heathcote, E. J. et al. | 2002
- 9
-
15-Deoxy-delta 12, 14-prostaglandin J2 inhibits proliferation of human myofibroblasts by a pathway involving heme-oxygenase-1Li, L. / Mallat, A. / Lotersztajn, S. et al. | 2002
- 9
-
In vivo antifibrogenic effects of histone deacetylase inhibitorsRombouts, K. / Gebretsadik, K. / Chavez, M. / Geerts, A. et al. | 2002
- 9
-
Cyclic AMP regulates hepatic stellate cells endothelin-A-receptor-sensitivity by receptor-phosphorylation and -internalisationReinehr, R. / Fischer, R. / Haeussinger, D. et al. | 2002
- 9
-
Full-length HBV genome analysis of isolates from serum and liver of lamivudine-treated patients with different clinical outcomeCerenzia, G. / Pollicino, T. / Squadrito, G. / Brancatelli, S. / Boni, C. / DiMarco, V. / Gaeta, G. / Panebianco, R. / Raimondo, G. et al. | 2002
- 10
-
gp130-dependent signaling induces acute phase gene expression and is crucial for survival after two-thirds partial hepatectomyWuestefeld, T. / Klein, C. / Streetz, K. L. / Betz, U. / Mueller, W. / Manns, M. P. / Trautwein, C. et al. | 2002
- 10
-
Molecular and cellular analysis of stellate cell activation -associated protein (STAP)Kawada, N. / Asahina, K. / Yoshizato, K. et al. | 2002
- 10
-
Insulin-like growth factor type-I (IGF-I) modulates the inflammatory response within the liverSanz, S. / Rodriguez-Ortigosa, C. M. / Lund, K. / Brenner, D. A. / Prieto, J. et al. | 2002
- 11
-
Low doses of IGF-1 decrease histological damage, portal pressure (PP) and bacterial translocation (BT) in rats with cirrhosis inductionZuniga, V. L. / Bartoli, R. / Planas, R. / Ortigosa, C. R. / Cortazar, I. C. / Vinado, B. / Ojanguren, I. / Quiroga, J. / Gassull, M. A. / Prieto, J. M. et al. | 2002
- 11
-
Tumor necrosis factor-alpha in cirrhotic cardiomyopathyLiu, H. / Lee, S. S. et al. | 2002
- 11
-
Tezosentan, a dual endothelin receptor antagonist, decreases mortality and liver injury in rats with cirrhosis following endotoxin administrationUrbanovicz, W. / Sogni, P. / Tazil, K. / Cazals-Hatem, D. / Barriere, E. / Poirel, O. / Moreau, R. / Lebrec, D. et al. | 2002
- 11
-
The tightly regulated inducible expression of the core protein of hepatitis C virus modulates Fas- and TNF alpha-mediated apoptosis in human liver cellsSacco, R. / Suzuki, R. / Aizaki, H. / Tsutsumi, T. / Otsuka, M. / Matsuda, M. / Seki, N. / Matsuura, Y. / Suzuki, T. / Miyamura, T. et al. | 2002
- 12
-
Increased systemic production of carbon monoxide in patients with cirrhosis and ascites with and without spontaneous bacterial peritonitis (SBP)De Las Heras, D. / Ortega, R. / Gines, P. / Cardenas, A. / Fernandez, J. / Guevara, M. / Calahorra, B. / Barbera, J. A. / Navasa, M. / Jimenez, W. et al. | 2002
- 12
-
The cannabinoid receptor CB1 compensates for deficient eNOS activity in ecNOS-knockout mice and is markedly upregulated in murine and human cirrhosisBiecker, E. / Saegesser, H. / Neef, M. / Sauerbruch, T. / Reichen, J. et al. | 2002
- 12
-
Randomized, double-blind, placebo controlled trial of RHU-EPO to improve platelet count and platelet function in alcoholic cirrhotics with thrombocytopeniaHomoncik, M. / Peck-Radosavljevic, M. / Laya, N. / Gangl, A. / Ferenci, P. / Jilma, B. et al. | 2002
- 13
-
Oral glutamine challenge correlates with minimal hepatic encephalopathy and predicts overt episodesGrande, L. / Camacho, I. / Benitez, S. / Romero-Gomez, M. et al. | 2002
- 13
-
Liver disease is a major cause of mortality following allogenic bone marrow transplantationEl-Sayed, M. / El-Haddad, A. / Fahmy, O. / Salama, I. / Mahmoud, H. et al. | 2002
- 14
-
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosisBogdanos, D. P. / Baum, H. / Sharma, U. C. / Grasso, A. / Ma, Y. / Burroughs, A. K. / Vergani, D. et al. | 2002
- 15
-
Effects of terlipressin administration with and without albumin in hepatorenal syndrome (HRS). A phase II studyOrtega, R. / Gines, P. / Uriz, J. / Calahorra, B. / Cardenas, A. / De Las Heras, D. / Guevarra, M. / Jimenez, W. / Arroyo, V. / Rodes, J. et al. | 2002
- 15
-
Vascular remodeling in cirrhosis: structural features and hemodynamic consequencesFernandez-Varo, G. / Ros, J. / Jimenez, W. / Cejudo-Martin, P. / Sole, M. / Arroyo, V. / Rivera, F. / Rodes, J. et al. | 2002
- 15
-
The HVPG-response to pharmacological treatment of portal hypertension predicts prognosis and the risk of developing complications of cirrhosisTarantino, I. / Abraldes, J. G. / Turnes, J. / Pagan, J. C. / Bosch, J. / Rodes, J. et al. | 2002
- 16
-
Child-PUGH- vs. meld-score to predict survival after tips: the Vienna-experience with 349 patients over 10 yearsCejna, M. / Karnel, F. / Gschwantler, M. / Pidlich, J. / Kreil, A. / Wichlas, M. / Mendel, H. / Pichler, L. / Brunner, H. / Gangl, A. et al. | 2002
- 16
-
Genetic evidence that fatty liver is involved in the pathogenesis of advanced alcoholic liver diseaseDay, C. / Leathart, J. / Daly, A. et al. | 2002
- 16
-
Thrombopoietin serum levels are elevated in patients with chronic virus hepatitis and controlled on a post-transcriptional levelTacke, F. / Schoffski, P. / Ganser, A. / Manns, M. P. / Trautwein, C. et al. | 2002
- 16
-
A trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitisStewart, S. / Prince, M. / Bassendine, M. / Hudson, M. / James, O. / Jones, D. / Record, C. / Day, C. et al. | 2002
- 17
-
Treatment with 40 kd pegylated (PEG)-interferon (IFN) alfa2a may overcome primary IFN-resistance in patients with chronic hepatitis C (Genotype 1)Jessner, W. / Hackl, F. / Stauber, R. / Datz, C. / Kessler, H. / Ferenci, P. et al. | 2002
- 17
-
Sero-lymphotropic copartimentalization of hepatitis C virus quasispecies and severity of liver diseaseRoque-Afonso, A. M. / Kara, R. / Ducoulombier, D. / Dussaix, E. / Guettier, C. / Samuel, D. / Feray, C. et al. | 2002
- 17
-
BCL-2 rearranged B cell clones in chronic HCV infection: a possibile factor negatively influencing the virological response to treatmentGiannelli, F. / Monti, M. / Caini, P. / Moscarella, S. / Romanelli, R. / Giannini, C. / Gragnani, L. / La Villa, G. / Laffi, G. / Gentilini, P. et al. | 2002
- 17
-
Vitamin E enhances the long-term response of CHC patients to IFN plus ribavirin therapyServiddio, G. / Altomare, E. / Prigigallo, F. / Vendemiale, G. et al. | 2002
- 18
-
Polymorphisms in the IFN-induced GNES PKR, OAS-1, MxA and the outcome of hepatitis C virus infectionKnapp, S. / Thomas, H. / Graves, M. / Hill, A. / Thursz, M. et al. | 2002
- 18
-
High viral response rates in previous nonresponder patients with hepatitis C treated with daily dosing of consensus interferon and ribavirinKaiser, S. / Kreysel, C. / Hass, H. / Gregor, M. et al. | 2002
- 18
-
Serum biochemical markers of liver fibrosis in human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-coinfected patientsMyers, R. P. / Benhamou, Y. / Bochet, M. / Imbert-Bismut, F. / Thibault, V. / Ratziu, V. / Charlotte, F. / Katlama, C. / Poynard, T. et al. | 2002
- 19
-
Telomere shortening inhibits progression of hepatoma in telomerase deficient miceRudolph, K. L. / Paraskevi, E. / DePinho, R. A. et al. | 2002
- 19
-
Cooperation of p18INK4c with p21CIP1/WAF1 and p27KIP1 in liver-regenerationLuedde, T. / Trautwein, C. / Rodriguez, M. E. / Brenner, D. A. / Xiong, Y. et al. | 2002
- 19
-
The repopulation of liver allografts with recipient bone marrow derived liver cells varies with time and between recipientsGranato, A. / Forbes, S. / Poulsom, R. / Muraca, M. / Quarta, M. / Rugge, M. / Alison, M. et al. | 2002
- 19
-
Direct demonstration of a lineage between hepatocytes and hepatocellular carcinomas in diethylnitrosamine-treated ratsBralet, M. P. / Pichard, V. / Ferry, N. et al. | 2002
- 20
-
The impact of surveillance on hepatocellular carcinoma. Detection and survival of 417 patients with compensated cirrhosis: a 12-year prospective cohort studySangiovanni, A. / Fasani, P. / Ronchi, G. / Donato, M. F. / De Fazio, C. / Del Ninno, E. / Lampertico, P. / de Franchis, R. / Colombo, M. et al. | 2002
- 20
-
Final results of the phase III trial of the German working party of regional chemotherapy (ART) comparing chemoocclusion vs. chemoperfusion for the treatment of advanced hepatocellular carcinomaRudolph, K. L. / Kirchhoff, T. / Chavan, A. / Galanski, M. / Gallkowski, U. / Layer, G. / Manns, M. P. / Kubicka, S. et al. | 2002
- 20
-
Role of deregulation of the APC-WNT-beta catenin signaling and microsatellite instability in hepatic carcinogenesis. Preliminary results in a series of 20 sporadic hepatoblastomas and 11 non virus-related hepatocellular carcinomasZuckermann, M. / Pinzani, M. / Curia, M. C. / Salini, C. / Aceto, G. / Catalano, T. / Battista, P. / Giuseppina, G. / Cama, A. / Mariani-Costantini, R. et al. | 2002
- 20
-
Bicistronic adenovirus for p53-dependent transgene expression as a tool for gene therapy of p53-altered cancer cellsKuehnel, F. / Zender, L. / Trautwein, C. / Manns, M. P. / Kubicka, S. et al. | 2002
- 21
-
Histological findings in the liver biopsy of morbidly obese patients with normal liver enzymesSepulveda, R. N. / Bosques, F. J. / Salinas, R. / Zorrilla, P. / Rumbaut, R. / Maldonado, H. / Vera, L. et al. | 2002
- 21
-
EGF increases c-Myc, which blocks the binding of C/EBP to DNA to downregulate CYP expressionTinel, M. / Berson, A. / Elkahwaji, J. / Cresteil, T. / Pessayre, D. et al. | 2002
- 21
-
High prevalence of non specific autoantibodies (NOSA) in NAFLD: does insulin resistance play a role?Loria, P. / Lonardo, A. / Fontana, M. C. / Muratori, P. / Cassani, F. / Leonardi, F. / Ganazzi, D. / Verrone, A. M. / Bagni, A. / Borsatti, A. et al. | 2002
- 21
-
CD14 promoter polymorphism associated with risk of NASHDay, C. et al. | 2002
- 22
-
Differential exhalation of volatile organic compounds in NASH, liver cirrhosis and healthy volunteers - a pilot studyMillonig, G. / Praun, S. / Eibl, G. / Villinger, J. / Vogel, W. et al. | 2002
- 22
-
In-vivo proton-decoupled 31P-magnetic resonance spectroscopic imaging for the determination of altered phosphoethanolamine levels in alcoholic liver diseaseSchlemmer, H. P. / Dornacher, I. / Sawatzki, T. / Hellenschmidt, M. / Bachert, P. / van Kaic, G. / Seitz, H. K. et al. | 2002
- 22
-
Long term prognosis of patients with alcoholic liver cirrhosis: results from a 15 year follow-up study of 100 Norwegian patientsBell, H. / Jahnsen, J. / Kittang, E. / Raknerud, N. / Sandvik, L. et al. | 2002
- 22
-
Hepatic and skeletal muscle glycogen metabolism in rats with short-term cholestasisLang, C. / Schafer, M. / Varga, L. / Zimmermann, A. / Krahenbuhl, S. / Krahenbuhl, L. et al. | 2002
- 23
-
Combinations of adefovir with lamivudine, entecavir, or L-dT produce additive antiviral effects against HBV in vitroDelaney, W. / Yang, H. / Miller, M. / Gibbs, C. / Xiong, S. et al. | 2002
- 23
-
Individual immune response to hepatitis A and B vaccine is mostly genetically determinedHoehler, T. / Fimmers, R. / Reuss, E. / Vollmar, J. / Dietrich, E. / Evers, N. / Galle, P. R. / Rittner, C. et al. | 2002
- 23
-
Mechanism of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionateSpaniol, M. / Kaufmann, P. / Beier, K. / Wuethrich, J. / Scharnagl, H. / Maerz, W. / Kraehenbuehl, S. et al. | 2002
- 23
-
Experimental transfection of macaca sylvanus with cloned human hepatitis B virusGheit, T. / Sekkat, S. / Cova, L. / Chevallier, M. / Petit, M. A. / Hantz, O. / Lesenechal, M. / Benslimane, A. / Trepo, C. / Chemin, I. et al. | 2002
- 24
-
Different proliferative and cytolytic function of memory HBV and HCV-specific cytotoxic T cells in acute hepatitis B and CBoni, C. / Urbani, S. / Missale, G. / Ferrari, C. et al. | 2002
- 24
-
Analysis of the immunomodulatory activity of levovirin, a second generation ribavirin analogue, on T-cell responses to hepatitis C virusHaigh, P. / Mullerova, I. / Tang, K. / Proto, S. / Chokshi, S. / Williams, R. / Lau, J. / Naoumov, N. et al. | 2002
- 24
-
Mutations within the CD81-binding sites and hypervariable region (HVR) 2 of the envelope (E) 2 protein and correlation with treatment response in HCV infected patientsHofmann, W. P. / Sarrazin, C. / Kronenberger, B. / Bruch, K. / Schonberger, B. / Zeuzem, S. et al. | 2002
- 24
-
Mutations located in the IRES, E1 and HVR of hepatitis C virus are involved in the sero-lymphocytic compartmentalizationDucoulombier, D. / Roque-Afonso, A. M. / Kara, R. / Gigou, M. / Dussaix, E. / Feray, C. et al. | 2002
- 25
-
Hepatocytic progenitor cells in primary culture from adult pancreasLardon, J. / Bouwens, L. et al. | 2002
- 25
-
Activation of RAF-1/MAPK/(727-Ser) STAT-1 pathway by HCV core protein causes a transcriptional induction of IFN-a inducible-genesGiambartolomei, S. / Cupelli, F. / Costanzo, A. / Levrero, M. / Balsano, C. et al. | 2002
- 25
-
Transplantation of bone marrow derived liver stem cells in a rodent model of liver transplantationFerraresso, C. / Avital, I. / Muraca, M. / Aoki, T. / Rozga, J. / Demetriou, A. et al. | 2002
- 25
-
Fatty degeneration exacerbates mitochondrial dysfunction in the rat liver exposed to preservation-reperfusion injuryCaraceni, P. / Domenicali, M. / Bianchi, C. / Maiolini, E. / Parenti-Castelli, G. / Lenaz, G. / Trevisani, F. / Bernardi, M. et al. | 2002
- 26
-
Ischaemic preconditioning lowers hepatic GSH and activates p38 and NFkappaB to promote cell cycle entry via cyclin D1: mechanism of protection against ischemia reperfusion injury in Micea brief period of hepatic ischaemia and reperfusion (preconditioning)Teoh, N. / dela Pena, A. / Farrell, G. et al. | 2002
- 26
-
Tacrolimus versus microemulsified cyclosporine in liver transplantation - the TMC randomised trial. Final results at one yearBurroughs, A. / Rolles, K. / Gimson, A. / Jamieson, N. / Hudson, M. / Thick, M. / O'Grady, J. / Heaton, N. / Mayer, D. / Neuberger, J. et al. | 2002
- 26
-
Liver transplantation in HIV-HCV coinfected patients. New indication and preliminary experienceSamuel, D. / Feray, C. / Vittecoq, D. / Azoulay, D. / Teicher, E. / Saliba, F. / Ichai, P. / Roque, A. M. / Castaing, D. / Adam, R. et al. | 2002
- 27
-
Development of liver specific and regulatable adenoviral vector for gene therapyWang, L. / Shankar, V. / Kochanek, S. / Qian, C. / Prieto, J. et al. | 2002
- 27
-
Outcome following listing for liver transplantation in primary sclerosing cholangitisBrandsaeter, B. / Friman, S. / Ericzon, B. G. / Hockerstedt, K. / Kierkegaard, P. / Olausson, M. / Broome, U. / Isoniemi, H. / Hansen, B. / Schrumpf, E. et al. | 2002
- 27
-
Italian experience on liver transplantation for hepatocellular carcinomaGianni, S. / Mirante, V. / Pompili, M. / Rapaccini, G. / Farinati, F. / Naccarato, R. / Gasbarrini, G. / Fagiuoli, S. et al. | 2002
- 28
-
Estrogens induce cholangiocyte proliferation through the activation of the ERK1/2 system and the adapter proteins Sch, and SrcAlvaro, D. / Alpini, G. / Onori, P. / Franchitto, A. / Glaser, S. / Le Sage, G. / Gigliozzi, A. / Attili, A. / Baronigaudio, G. S. / Metalli, V. D. et al. | 2002
- 28
-
Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis resembling alcoholic human diseaseSiller, F. / Salgado, S. / Garcia, J. / Vera, J. M. / Miranda, A. / Grijalva, G. / Galvez, J. / Aguilar-Cordova, E. / Armendariz-Borunda, J. et al. | 2002
- 28
-
Alterations of hepatobiliary transporter expression in primary biliary cirrhosis (PBC)Zollner, G. / Fickert, P. / Silbert, D. / Fuchsbichler, A. / Stumptner, C. / Neuberger, J. / Zatloukal, K. / Denk, H. / Trauner, M. et al. | 2002
- 28
-
Truncated type II TGF-beta receptor promotes liver regeneration in dimetylnitrosamin-treated cirrohotic ratsNakamura, T. / Sakata, R. / Sakamoto, M. / Torimura, T. / Ueno, T. / Sata, M. et al. | 2002
- 29
-
Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?Celik, T. / Aslan, N. / Goren, Z. / Gurdal, H. / Degim, T. / Toruner, M. / Cinar, K. / Uzbay, T. / Bozkaya, H. / Yurdaydin, C. et al. | 2002
- 29
-
Reduced pallidal magnetisation transfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis (PBC)Forton, D. / Prince, M. / Allsop, J. / Patel, N. / Goldblatt, J. / Thomas, H. / Bassendine, M. / Jones, D. / Taylor-Robinson, S. et al. | 2002
- 29
-
Biliary atresia does not inevitably lead to chronic liver disease or transplantationTizzard, S. / Hadzic, N. / Davenport, M. / Singer, J. / Howard, E. R. / Mieli-Vergani, G. et al. | 2002
- 30
-
Acquisition, storage and release of iron by cultured human hepatoma cellsHirsh, M. / Konijn, A. M. / Iancu, T. C. et al. | 2002
- 31
-
Tacrolimus dual therapy versus cyclosporin-microemulsion triple therapy in paediatric liver transplant recipients: results of a 12-month comparative studyRodeck, B. / Kelly, D. / Jara, P. / Reding, R. / Bernard, O. / Burdelski, M. / Becker, M. / Gridelli, B. / Boillot, O. / Manzanares, J. et al. | 2002
- 31
-
Hepatic ischemic preconditioning is most effective in patients with a small resection volume and long ischemic intervals: a prospective randomized study in 100 patientsRudiger, H. A. / Kang, K. J. / Selzner, M. / Selzner, N. / Dindo, D. R. / Riehle, H. M. / Jochum, W. / Kadry, Z. / Clavien, P. A. et al. | 2002
- 31
-
Current results of living-related liver transplantation (LRLT) in Europe. Report from the European Liver Transplantation Registry (ELTR)Adam, R. / Karam, V. / Delvart, V. / Hockerstedt, K. et al. | 2002
- 32
-
HCV recurrence after OLT: no influence of donor age or sex mismatch on fibrosis - a prospectively biopsied cohortTeixeira, R. / Papatheodoridis, G. / Raimondo, M. L. / Sabin, C. / Davis, S. / Dillon, A. / Dagher, L. / Pastacaldi, S. / Davidson, B. / Rolles, K. et al. | 2002
- 32
-
Adefovir dipivoxil (ADV) for the treatment of lamivudine resistant HBV (LAM-R) in post liver transplant (post-OLT) patientsSchiff, E. / Neuhaus, P. / Tillman, H. / Samuel, D. / Terrault, N. / Durand, F. / Xiong, S. / Lama, N. / James, C. / Fry, J. et al. | 2002
- 32
-
Anti-HCV human immunoglobulins for the prevention of graft infection in HCV-related liver transplantation, a pilot studyWillems, B. / Ede, M. / Marotta, P. / Wall, W. / Greig, P. / Lilly, L. / Kneteman, N. / Wong, W. / Roy, A. / Marleau, D. et al. | 2002
- 33
-
Lactulose therapy in acute liver failureAlba, L. / Hay, J. E. / Angulo, P. / Lee, W. M. et al. | 2002
- 33
-
A systematic review on extracorporeal liver support for liver failureLiu, J. / Kjaergard, L. L. / Als-Nielsen, B. / Gluud, C. et al. | 2002
- 33
-
Towards an extension of the indications of liver transplantation (LT) for hepatocellular carcinoma with cirrhosis?Adam, R. / Azoulay, D. / Castaing, D. / Veilhan, L. A. / Samuel, D. / Saliba, F. / Feray, C. / Bismuth, H. et al. | 2002
- 34
-
Role of anti-tumor necrosis factor-alpha in ischemia/reperfusion injury in isolated rat liver in a blood-free environmentBen-Ari, Z. / Hochhauser, E. / Papo, O. / Vidne, B. et al. | 2002
- 34
-
Passive immunoprophylaxis and liver transplantationBihl, F. / Knoepfli, M. / Castelli, D. / Cerny, A. et al. | 2002
- 34
-
Retransplantation of the liver: a reappraisal in the era of combined organ shortage and economical constraintsAzoulay, D. / Samuel, D. / Castaing, D. / Adam, R. / Saliba, F. / Ichai, P. / Bismuth, H. et al. | 2002
- 34
-
The efficacy of tacrolimus versus microemulsified cyclosporin in prevention of early acute cellular rejection following liver transplantation: a histopathological assessment; on behalf of the UK and Republic of Ireland liver transplant study groupArul, D. / Burroughs, A. / Truesdale, A. / Elbourne, D. / Hardy, P. / Davies, S. et al. | 2002
- 35
-
Passive immunoprophylaxis to prevent hepatitis B virus reccurence after orthotopic liver transplantation: comparison of ANTI-HBs plasma to commercial immune globuline preparationsBihl, F. / Knoepfli, M. / Castelli, D. / Cerny, A. et al. | 2002
- 35
-
Billary strictures (hilar or anastomotic) after liver transplantation (LT)Bourgeois, N. / Boon, N. / Donckier, V. / Hut, F. / Gustoi, T. / Le Moine, O. / Lefebvre, V. / El Nakadi, I. / Louis, H. / Matos, C. et al. | 2002
- 35
-
Changes in porto-hepatic hemodynamics during acute rejection (AR) in patients with liver transplant (OLT)Bolognesi, M. / Nava, V. / Sacerdoti, D. / Bombonato, G. / Sartori, G. / Gatta, A. et al. | 2002
- 36
-
Genetic evolution of hepatitis C virus after liver transplantationFeliu, A. / Forns, X. / Garcia-Retortillo, M. / Moitinho, E. / Rodes, J. et al. | 2002
- 36
-
Liver cell proliferation and severity of hepatitis C recurrence after liver transplantDonato, M. F. / Agnelli, F. / Arosio, E. / Monti, V. / Balestrieri, M. R. / Rizzi, P. / Colombo, M. et al. | 2002
- 36
-
Level of replication and genotypes of hepatitis A virus in fulminant and non-fulminant hepatitisRezende, G. / Roque-Afonso, A. M. / Dussaix, E. / Samuel, D. / Gigou, M. / Feray, C. et al. | 2002
- 36
-
Non virological factors associated with fibrosis progression after hepatitis C virus (HCV) graft reinfectionMennecier, D. / Roudot-Thoraval, F. / Pageaux, G. P. / Conti, F. / Dhumeaux, D. / Duvoux, C. et al. | 2002
- 37
-
Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriersGaia, S. / Marzano, A. / Ciardo, V. / Gentilcore, E. / Lagget, M. / Smedile, A. / Rizzetto, M. et al. | 2002
- 37
-
Eradication of allograft HBV infection with lamivudine/low dose HBIG prophylaxis: a precursor to safe HBIG withdrawal?Gane, E. / Bowden, S. / Schroeder, B. / Munn, S. / Locarnini, S. et al. | 2002
- 37
-
Donor evaluation in living related liver transplantation: a new non-invasive methodFrericks, B. / Calderone, F. / Schenk, A. / Peitgen, H. / Nashan, B. / Galanski, M. et al. | 2002
- 38
-
Renal dysfunction (RD) following orthotopic liver transplantation (OLT): role of cyclosporine (CsA) elimination as provided by the neoral (NEO) formulationHuet, P. M. / Marleau, D. / Hauck, W. et al. | 2002
- 38
-
Relationship between alcoholic relapse, non compliance and histological lesions after liver transplantation (LT) for alcoholic cirrhosis (AC)Hurtova, M. / Duclos-Vallee, J. C. / Delvart, V. / Karam, V. / Saliba, F. / Ichai, P. / Feray, C. / Guettier, C. / Bismuth, H. / Samuel, D. et al. | 2002
- 38
-
Prophylactic banding ligation of high risk esophageal varices inpatients on the waiting list for liver transplantation: an interim reportGheorghe, C. / Gheorghe, L. / Vadan, R. / Hrehoret, D. / Popescu, I. et al. | 2002
- 39
-
Impact of peroxynitrite in analytical errors of laboratory tests of liver functionKocic, R. / Kocic, G. / Kundalic, S. / Djordjevic, V. / Pavlovic, D. et al. | 2002
- 39
-
Fulminant hepatitis consecutive to grand mal seizures: mechanisms, role of drugs, of hypoxemia and place of liver transplantation (LT)Ichai, P. / Guettier, C. / Saliba, F. / Azoulay, D. / Castaing, D. / Bismuth, H. / Samuel, D. et al. | 2002
- 39
-
iNOS and eNOS expression in fulminant hepatic failureLeifeld, L. / Fielenbach, M. / Franz-Ludwig, D. / Tilman, S. / Ulrich, S. et al. | 2002
- 39
-
The labile iron pool of hepatocytes in chronic and acute iron overload and chelator-induced iron deprivationZanninelli, G. / Loreal, O. / Brissot, P. / Konijn, A. M. / Slotki, I. N. / Hider, R. C. / Ioav Cabantchik, Z. et al. | 2002
- 39
-
Ribavirin monotherapy in liver transplant recipients with recurrent hepatitis CLionetti, R. / Tisone, G. / Di Paolo, D. / Zazza, S. / Casarelli, F. / Manzia, T. M. / Petrolati, A. / Cepparulo, M. / Angelico, M. et al. | 2002
- 40
-
Characterisation of intrahepatic T, NKT and NK cells in liver transplant recipients with HCV cirrhosisMorsy, M. A. / Norman, P. J. / Rela, M. / Heaton, N. D. / Vaughan, R. W. et al. | 2002
- 40
-
Right split in situ grafts and whole grafts in adult recipientsMaggi, U. / Rossi, G. / Reggiani, P. / Caccamo, L. / Gatti, S. / Paone, G. / Melada, E. / Olmetti, S. / Doglia, M. / Fassati, L. R. et al. | 2002
- 40
-
Localization of chlamydia pneumoniae by immunohistochemistry and in situ PCR in chronic liver allograft rejection with obliterative arteriopathyLotz, G. / Patonai, A. / Simon, S. / Sergi, C. / Nashan, B. / Schaff, Z. et al. | 2002
- 41
-
Hyperuricaemia, gout and cardiovascular risk after liver transplantationNeal, D. / Tom, B. / Gimson, A. / Gibbs, P. / Alexander, G. et al. | 2002
- 41
-
Hepatocyte transplantation as a treatment for glycogen storage disease type IAMuraca, M. / Gerunda, G. / Neri, D. / Vilei, M. T. / Granato, A. / Feltracco, P. / Giron, G. / Burlina, A. B. et al. | 2002
- 41
-
Consequences of severe alcoholic relapse after liver transplantation (LT) for alcoholic cirrhosis (AC)Pageaux, G. P. / Bismuth, M. / Perney, P. / Coste, V. / Jaber, S. / Fabre, J. M. / Blanc, P. / Domergue, J. / Larrey, D. et al. | 2002
- 41
-
Functional liver plasma flow after orthotopic liver transplantation (OLT)Pollet, C. / Bar, F. / Battista, S. / Peola, D. / Gariboldi, A. / Bucchi, M. C. / Salizzoni, M. / Cerutti, E. / Molino, G. et al. | 2002
- 42
-
Short-term mechanical hyperventilation does not reduce cerebral oxidative metabolism in patients with fulminant hepatic failure (FHF)Strauss, G. I. / Moeller, K. / Knudsen, G. M. / Larsen, F. S. et al. | 2002
- 42
-
Hypoxia inducible factor 1 (HIF 1) is over expressed in acute rejection following liver transplantationRichards, T. / Stroka, D. / Candinas, D. et al. | 2002
- 42
-
VEGF effect on hepatocyte engraftment after intrasplenic cell transplantation in ratsShani, H. / Tsiperson, V. / Shoshany, G. / Neufeld, G. / Baruch, Y. et al. | 2002
- 42
-
Adefovir therapy for HBV infection after liver transplantation (LT)Roche, B. / Roque-Afonso, A. M. / Feray, C. / Duclos-Vallee, J. C. / Bismuth, H. / Samuel, D. et al. | 2002
- 43
-
CTLA-4 recipient polymorphism influences HCV liver disease recurrence following orthotopic liver transplantation (OLT)Valenti, L. / Spatola, V. / Fatta, E. / Dongiovanni, P. / Rossi, G. / Fiorelli, G. / Fassati, L. R. / Fargion, S. R. et al. | 2002
- 43
-
Nasal mucosal changes in cirrhotics, a clinico-histopathological studyIbrahim, A. E. / Selit, A. M. / Khamis, N. S. et al. | 2002
- 43
-
Study risk factors for cholangitis post hepat olithiasis ERCPAbul Futuh, A. R. / Hamed, W. / Soliman, A. G. / El-Hadad, S. / Omar, M. / El-Hendawy, S. et al. | 2002
- 43
-
Rapid fibrosis in hepatitis C virus genotype 4 (HCV4) patients after liver transplantation (LT)Wali, M. H. / Heydtmann, M. / Harrison, R. / Hubscher, S. / Gunson, B. / Mutimer, D. et al. | 2002
- 44
-
Selective intestinal decontamination (SID) ameliorates the immune and hemodynamic derangement of cirrhotic patients with high levels of lyposyccharide-binding protein (LBP)Albillos, A. / Hera, A. / Gonzalez, M. / Moya, J. L. / Calleja, J. L. / Monserrat, J. / Ruiz-Del-Albeniz, E. / Ruiz-Del-Arbol, L. / Alvarez-Mon, M. et al. | 2002
- 44
-
High portal adrenomedullin levels in complicated human liver cirrhosis are related to local factors in the portal tractBar, F. / Battista, S. / Mengozzi, G. / Pollet, C. / Peola, D. / Aimo, G. / Molino, G. et al. | 2002
- 44
-
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosisAnde, S. / Wiemann, S. / Tsahuridu, M. / Tillmann, H. / Manns, M. P. / Rudolph, K. L. et al. | 2002
- 44
-
Endoscopic treatment versus endoscopic plus pharmacologic treatment for variceal bleedingBanares, R. / Albillos, A. / Rincon, D. / Alonso, S. / Gonzalez, M. / Ruiz-del-Arbol, L. / Salcedo, M. / Molinero, L. M. et al. | 2002
- 45
-
Portal encephalopathy at patients with decompensated hepatic cirrhosis and ascitesBezna, S. / Marinela, B. / Ciurea, P. / Ciurea, T. et al. | 2002
- 45
-
Hemorrhage and cirrhosis in the prophylactic era: the need for very early managementNidegger, D. / Ragot, S. / Beauchant, M. et al. | 2002
- 45
-
Impaired psychological status in cirrhotic patientsBianchi, G. / Baroni, M. / Brunetti, N. / Sartoni, G. / Dapporto, S. / Marchesini, G. / Zoli, M. et al. | 2002
- 45
-
NOS-1 compensates for NOS-3 deficiency in NOS-3 knockout mice and is upregulated in cirrhosisBiecker, E. / Saegesser, H. / Shaw, S. / Reichen, J. et al. | 2002
- 46
-
AMP deaminase activity and urate levels in liver cirrhosisNagorni, A. / Kocic, G. / Jeftovic, T. / Sokolovic, D. / Vukotic, N. / Bjelakovic, G. et al. | 2002
- 46
-
Risk factors for distal renal tubular acidosis in chronic liver diseasesFarias, A. / Goncalves, L. / Seguro, A. C. / Campos, S. B. / Assuncao, S. / Abrantes-Lemos, C. / Porta, G. / Carrilho, F. / Bittencourt, P. / Miura, I. et al. | 2002
- 47
-
Effect of octreotide on IL-6 and IL-8 release and on aortic ethanol induced hyporeactivity in rats with portal hypertensionChagneau, C. / Lecron, J. C. / Becq-Giraudon, L. / Cappelin, B. / Beauchant, M. / Robert, R. / Silvain, C. et al. | 2002
- 47
-
Platelet count: a simple marker of liver cirrhosis in chronic hepatitis C (CHC) infectionBorroni, G. / Ceriani, R. / Tommasini, M. A. / Maltempo, C. / Felline, C. / Contu, L. / Cazzaniga, M. et al. | 2002
- 47
-
Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phaseOneta, C. M. / Lieber, C. S. / Li, J. / Ruttimann, S. / Schmid, B. / Lattmann, J. / Rosman, A. S. / Seitz, H. K. et al. | 2002
- 47
-
Gender differences in aortic reactivity in rats with portal hypertensionChagneau, C. / Laboureyras, E. / Silvain, C. / Leboeuf, D. / Beauchant, M. / Robert, R. et al. | 2002
- 47
-
Relationships between MELD scoring system, Child-Pugh's score, and residual liver function in a European series of cirrhotic patientsBotta, F. / Giannini, E. / Romagnoli, P. / Fasoli, A. / Malfatti, F. / Chiarbonello, B. / Testa, E. / Polegato, S. / Fumagalli, A. / Risso, D. et al. | 2002
- 48
-
The effect of the administration of aminoguanidine and L-arginine on the bacterial translocation in experimental cirrhosisCasafont, F. / Guerra, M. H. / Pajares, F. G. / Guerra, A. / Cayon, A. / de Benito, I. / Romero, F. P. et al. | 2002
- 48
-
Experimental biliary cirrhosis in rat - impact on small intestineCervinkova, Z. / Radvakova, D. et al. | 2002
- 48
-
Rapid diagnosis of spontaneous bacterial peritonitis and empyema by use of reagent stripsCastellote, J. / Xiol, X. / Tremosa, G. / Gornals, J. B. / Lopez, C. / Rodriguez-Farinas, E. / Baliellas, C. et al. | 2002
- 48
-
The effect of transjugular intrahepatic portosystemic shunt (TIPS) on portal hypertensive gastropathyChoi, S. K. / Lee, W. S. / Joo, Y. E. / Rew, J. S. / Kim, J. K. / Kim, S. J. et al. | 2002
- 49
-
Influence of posture on haemodynamics, sodium and hormonal homeostasisin cirrhotic patients with and without ascitesColle, I. / Schoors, D. / Van Vlierberghe, H. / Van Maele, G. / De Vos, M. / Reynaert, H. et al. | 2002
- 49
-
Reversal of type I hepatorenal syndrome (HRS) with therlipressine and octreotideCopaci, I. / Voiculescu, M. / Micu, L. / Cojocaru, L. / Constantinescu, G. et al. | 2002
- 49
-
Novel spin trap findings demonstrating severe oxidative stress in alcoholic hepatitisDavies, N. / Hodges, S. / Sen, S. / Mookerjee, R. P. / Cooper, C. / Jalan, R. et al. | 2002
- 49
-
Sirolimus, but not losartan, significantly reduces liver fibrosis and mortality in bile duct ligated ratsDe Gottardi, A. / Unternaehrer, M. / Saegesser, H. / Ledermann, M. / Reichen, J. et al. | 2002
- 50
-
Effects of nitric oxide syntase-inhibitors on early hepatic fibrosis induced by bile duct ligationMesonero, M. J. / Vazquez-Gil, M. J. / Flores, O. / Criado, M. / Lopez-Novoa, J. M. / Esteller, A. et al. | 2002
- 50
-
Impaired intestinal permeability in liver cirrhosis. Association with bacterial spontaneous peritonitis and hepatic encephalopathyDumitrascu, D. L. / Tamas, S. / Savuli, I. / Cotul, S. O. / Andreica, V. / Dragoteanu, M. et al. | 2002
- 50
-
Clinico-pathological, immunological and virological characteristics of patients transplanted for cryptogenic cirrhosisDuclos-Vallee, J. C. / Johanet, C. / Roque, A. M. / Gigou, M. / Feray, C. / Emile, J. F. / Sebagh, M. / Bismuth, H. / Samuel, D. / Guettier, C. et al. | 2002
- 51
-
Lithium clearance (C1Li) and its predictive value on ascites-related complications in hepatic cirrhosisFasolato, S. / Angeli, P. / Craighero, R. / Quarello, A. / Galioto, A. / Serianni, G. / Libera, V. D. / Sticca, A. / Del Piccolo, F. / Gatta, A. et al. | 2002
- 51
-
Hemodynamic effects of albumin administration in spontaneous bacterial peritonitisFernandez, J. / Navasa, M. / Gonzalez-Abraldes, J. / Garcia-Pagan, J. C. / Jimenez, W. / Bosch, J. / Rodes, J. et al. | 2002
- 51
-
Non-invasive diagnosis of hepatic cirrhosis by levovistFeliciangeli, G. / Argalia, G. / Marucci, L. / Abbatista, T. / Urbani, M. / Benedetti, A. et al. | 2002
- 52
-
The hemodynamic role of angiotensine II antagonist losartan inpatients with advanced cirrhosisFierbinteanu-Braticevici, C. / Tribus, L. / Andronescu, D. et al. | 2002
- 52
-
Sleep: a privileged window to the neurophysiological study of low grade hepatic encephalopathyMartino, M. E. / Fernandez-Lorente, J. / Romero-Vives, M. / de Vicente, E. / Barcena, R. / Gaztelu, J. M. et al. | 2002
- 52
-
Hemodynamic and antifibrotic effects of the early and chronic administration of propranolol in two intrahepatic portal hypertensive models in ratsWang, J. / Oberti, C. / Moal, F. / Croquet, V. / Vuillemin, E. / Roux, J. / Gallois, Y. / Cales, P. et al. | 2002
- 52
-
AST/ALT ratio has prognostic value in the assessment of 1-year survival of patients with viral cirrhosis: comparison with MELD and Child-Pugh's scoresGiannini, E. / Botta, F. / Chiarbonello, B. / Fumagalli, A. / Malfatti, F. / Polegato, S. / Romagnoli, P. / Testa, E. / Testa, R. et al. | 2002
- 53
-
Leukocyte recruitment in hepatic injury: selectin-mediated leukocyte rolling is a prerequisite for CD18-dependent firm adhesionKlintman, D. / Schramm, R. / Menger, M. D. / Thorlacius, H. et al. | 2002
- 53
-
Nutritional status and renal function in the prognostic evaluation of cirrhosis; comparison with Pugh's score and MELDGunsar, F. / Raimondo, M. L. / Terreni, N. / Wong, C. / Patch, D. / Sabin, C. / Burroughs, A. K. et al. | 2002
- 53
-
Interaction of hepatitis C virus (HCV) core protein with cell cyclecontrol check point (G1/S) in liver cells: a significance for the development of hepatocellular carcinoma (HCC)Hassanan, M. / Haeussinger, D. et al. | 2002
- 53
-
Low dose losartan reduces portal pressure, improves kidney function and vascular contractility in cirrhotic rats without affecting arterial pressureHeller, J. / Trebicka, J. / Shiozawa, T. / Schepke, M. / Neef, M. / Sauerbruch, T. et al. | 2002
- 53
-
Arterial oxygenation abnormalities in cirrhotics. Prevalence and predictive factors in hepatopulmonary syndromeGoritsas, C. / Kerenidi, T. / Batsakis, C. / Hasapis, C. / Zervas, E. / Angelis, P. / Ferti, A. et al. | 2002
- 54
-
Predictive factors of spontaneous bacterial peritonitis: univariate and multivariate analysisIacob, R. / Iacob, S. / Diculescu, M. et al. | 2002
- 54
-
Comparison of quantitative liver function tests and common prognostic scores in patients with primary biliary cirrhosisHerold, C. / Deynet, C. / Ganslmayer, M. / Hahn, E. G. / Schuppan, D. et al. | 2002
- 54
-
Prospective randomized trial of intravenous Ciprofloxacin for prevention of bacterial infection in cirrhotic patients with variceal bleedingHong, S. N. / Rhyu, M. K. / Lee, J. H. / Choi, M. S. / Koh, K. C. / Kim, Y. H. / Kim, J. J. / Paik, S. W. / Lee, J. C. / Choi, K. W. et al. | 2002
- 55
-
Usefullness of routine analysis of ascites fluid at the time of therapeutic paracentesis in asymptomatic cirrhotic out patientsCadranel, J. F. / Romney, R. / Mathurin, P. / Ganne-Carrie, N. / Halimi, C. / Medini, A. / Chaput, J. C. / Cruaud, P. / Pauwels, A. / Lemaitre, P. et al. | 2002
- 55
-
Olfactory functions in patients with hepatic cirrhosis and without overt hepatic encephalopathyJovic, J. / Jovic, N. et al. | 2002
- 55
-
Increased cerebral and peripheral vasodilation, and whole body nitricoxide (NO) production after insertion of a transjugular intrahepatic portosystemic stent-shunt (TIPSS) in patients with cirrhosisJalan, R. / Damink, S. O. / Deutz, N. / Redhead, D. / Lee, A. et al. | 2002
- 55
-
Compliance of cirrhotic patients with spontaneous bacterial peritonitis to prophylacyic antibiotic therapy: influence on recurrenceSimionov, I. / Gheorghe, L. / Gheorghe, C. / Vadan, R. et al. | 2002
- 56
-
Cortical activations by critical Flicker frequency in hepatic encephalopathy - an event related f-MRI studyKircheis, G. / Zafiris, O. / Boers, F. / Haeussinger, D. / Zilles, K. et al. | 2002
- 56
-
Therapeutic improvement of impaired albumin transport function in excretory liver failure by artificial liver support compared to conventional therapyLoock, J. / Peters, E. / Mitzner, S. / Liebe, S. / Klammt, S. et al. | 2002
- 56
-
The effect of terlipressin on blood volume distribution in patients with cirrhosisKiszka-Kanowitz, M. / Henriksen, J. H. / Hansen, E. F. / Moller, S. / Bendtsen, F. et al. | 2002
- 56
-
Prevalence of cardiac disease in primary biliary cirrhosisRichardson, C. E. / Kingham, J. G. et al. | 2002
- 57
-
Serum hyaluronic acid as a marker of hepatic fibrosis in patients with chronic liver diseasesKupcova, V. / Valkova, M. / Turecky, L. / Szantova, M. et al. | 2002
- 57
-
The role of the IL6/gp130 system for liver disease progressionStreetz, K. L. / Wuestefeld, T. / Leifeld, L. / Tacke, F. / Graw, A. / Kamino, K. / Schuetz, G. / Mueller, W. / Manns, M. P. / Trautwein, C. et al. | 2002
- 57
-
Natural history of compensated cirrhosisMoschandrea, J. / Koulentaki, M. / Oekonomaki, E. / Leontidis, C. H. / Samonakis, D. / Skordilis, P. / Kouroumalis, E. et al. | 2002
- 57
-
Ursodeoxycolic acid (UDCA) increases survival of primary biliary cirrhosis (PBC) and autoimmune cholangitis (AIC) patientsKoulentaki, M. / Moschandrea, J. / Dimoulios, P. H. / Hatzikostas, K. / Skordilis, P. / Kouroumalis, E. et al. | 2002
- 58
-
Advanced glykation end products in patients with liver cirrhosis before and after liver transplantationKupcova, V. / Sebekova, K. / Schinzel, R. / Heidland, A. et al. | 2002
- 58
-
Basal hyperactivity of neutrophil oxidative burst in chronic liver diseaseLidder, S. / Sen, S. / Mookerjee, R. P. / Hodges, S. / Davies, N. / Jalan, R. et al. | 2002
- 58
-
Large volume paracentesis as compared with the association clonidine- spironolactone in cirrhosis with refractory ascitesLenaerts, A. / Codden, T. / Van Cauter, J. / Henry, J. P. / Ligny, G. et al. | 2002
- 59
-
The inactive form of matrix metalloproteinase-9 is stored by liver collagens via the collagenous motive (GLY-PRO-HYP) XRuehl, M. / Somasundaram, R. / Farndale, R. / Knight, G. / Schmid, M. / Ackermann, R. / Zeitz, M. / Schuppan, D. et al. | 2002
- 59
-
Metabolic changes caused by a different value of nitric oxide in the liver of rats with dimethylnitrosoamine (DMN)-induced fibrosisLukivskaya, O. Y. / Zwierz, K. / Zavodnik, L. et al. | 2002
- 59
-
Is there any effect of propanolol therapy on the development of spontaneous bacterial peritonitis (SBP) in cirrhotic patients with ascites?Cholongitas, E. / Papatheodoridis, G. / Manesis, E. et al. | 2002
- 59
-
Octreotide for acute esophageal variceal bleedingNaumovski-Mihalic, S. / Colic-Cvrlje, V. / Katicic, M. / Scrbec, B. / Colic, A. et al. | 2002
- 59
-
Serum leptin levels in cirrhotic childrenOzcay, F. / Kocak, N. / Yuce, A. / Ozen, H. / Gurakan, F. / Saltik, I. N. / Demir, H. et al. | 2002
- 60
-
Usual biochemical tests are not suitable surrogate markers for the degree of liver fibrosisCales, P. / Oberti, F. / Rousselet, M. C. / Gallois, Y. / Bedossa, P. et al. | 2002
- 60
-
SNCF: a non invasive score to reduce the false negative rate of liver biopsies for cirrhosisWinkfield, B. / Oberti, F. / Aube, C. / Vuillemin, E. / Rousselet, M. C. / Cales, P. et al. | 2002
- 60
-
Essential systemic hypertension and viral chronic liver diseaseParrilli, G. / Orsini, L. / Vecchione, R. / Terracciano, L. M. / Abazia, C. / Manguso, F. / Budillon, G. et al. | 2002
- 60
-
Evaluation of Baveno criteria for grading esophageal varicesCales, P. / Oberti, F. / Bernard, B. / Payen, J. L. et al. | 2002
- 60
-
Serum ceruloplasmin and ferroxidase activity are decreased in HFE C282Y homozygote male iron-overloaded patientsLaine, F. / Ropert, M. / Lan, C. L. / Loreal, O. / Bellissant, E. / Jard, C. / Pouchard, M. / Treut, A. L. / Brissot, P. et al. | 2002
- 61
-
Bile acids stimulate adrenomedullin production in rat aorta: a novel mechanism contributing to hyperdynamic circulation in portal hypertensionPopescu, A. / Reichen, J. / Shaw, S. et al. | 2002
- 61
-
Presence of esophageal varices in patients with a recent histoligic diagnosis of cirrhosis of the liver: evaluation of clinical predictorsPrimignani, M. / Savojardo, V. / Dell'Era, A. / Fazzini, L. / Zatelli, S. / Pedotti, P. / Taioli, E. / de Franchis, R. et al. | 2002
- 61
-
HCV RNA quantitation in hepatic veins and peripheral blood in patients with cirrhosis: evidence for low level intrahepatic replicationBellis, L. / Castellacci, R. / Bergami, N. / Aldegheri, L. / Montagnese, F. / Pace, M. / Puoti, C. et al. | 2002
- 62
-
Postural instability in patients with liver cirrhosisSchmid, M. / Mittermayer, C. / Voller, B. / Fialka-Moser, V. / Gangl, A. / Peck-Radosavljevic, M. et al. | 2002
- 62
-
Hypersensitivity of monocytes from cirrhotic patients to endotoxin administration. Effects of lipoproteins and albuminRamirez, M. J. / Navasa, M. / Titos, E. / Jimenez, W. / Rodes, J. et al. | 2002
- 62
-
Detailed nature of aldosterone-dependent derangement of renal tubular function in nonazotemic human cirrhosis with ascitesSansoe, G. / Silvano, S. / Touscoz, A. / Mengozzi, G. / Smedile, A. / Rosina, F. / Bonardi, L. / Rizzetto, M. et al. | 2002
- 62
-
Comparison between intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of bacterial infections in cirrhotic patients with ascitesCraighero, R. / Angeli, P. / Antona, C. / Donada, C. / Luigi, B. / Roner, P. / Fasolato, S. / Sticca, A. / Gatta, A. et al. | 2002
- 63
-
Hyperdynamic circulation in portal hypertensive rats is dependent on intact vagal innervationSong, D. / Sharkey, K. / Lee, S. et al. | 2002
- 63
-
Liver/intestinal collagens type I, III and VI bind keratinocyte growth factor (KGF/FGF-7) via the collagenous binding motives (GPO) X and (GPP) XSomasundaram, R. / Ruehl, M. / Schoenfelder, I. / Farndale, R. / Knight, G. / Schmid, M. / Ackermann, R. / Zeitz, M. / Schuppan, D. et al. | 2002
- 63
-
Endoscopic variceal ligation compared with endoscopic sclerotherapy for variceal bleedingSerwah, A. H. / Habba, M. / Abdel-Hamid, A. et al. | 2002
- 63
-
Ammonia and partial pressure of ammonia - correlation with postural control, Child-Pugh-stage and reitan a test in patients with cirrhosisSchmid, M. / Mittermayer, C. / Funk, G. C. / Voller, B. / Fialka-Moser, V. / Gangl, A. / Peck-Radosavljevic, M. et al. | 2002
- 64
-
Increase in thyroid resistance indices in cirrhosis: relationships with volume, hormones, and hemodynamicsSacerdoti, D. / Bolognesi, M. / Bombonato, G. / Pierobon, A. / Gatta, A. / Spadaro, L. et al. | 2002
- 64
-
Spur cell anaemia in hepatic cirrhosis: incidence, prognosis and reversibility after liver transplantationSousa, J. M. / Giraldez, A. / De Blas, J. M. / Diaz, C. / Pareja, F. / Serrano, J. / Garcia, I. / Tamayo, M. J. / Gomez, M. A. / Perez, J. B. et al. | 2002
- 64
-
Captopril reduced portal pressure in cirrhotic patients with low portal venous velocityBaik, S. K. / Kim, Y. J. / Park, D. H. / Kim, M. Y. / Choi, Y. J. / Jung, P. H. / Seo, J. I. / Kim, H. S. / Lee, D. K. / Kwon, S. O. et al. | 2002
- 65
-
Erythropoietin plasma levels are elevated in chronic liver disease and correlate with anemia, liver dysfunction, bleeding episodes and interleukin-6Tacke, F. / Schoffski, P. / Ganser, A. / Manns, M. P. / Trautwein, C. et al. | 2002
- 65
-
Diagnostic accuracy of a rapid urine screening test (multistix 8SG) in cirrhotic patients with spontaneous bacterial peritonitisVanbiervliet, G. / Rampal, P. / Tran, A. et al. | 2002
- 65
-
Cortical origin of mini-asterixis in hepatic encephalopathyTimmermann, L. / Gross, J. / Kircheis, G. / Butz, M. / Haeussinger, D. / Schnitzler, A. et al. | 2002
- 66
-
Haemodynamic effects of chronic administration of losartan, an angiotensin II receptor anatagonist, in patients with cirrhosis and portal hypertensionTripathi, D. / Therapondos, G. / Lui, H. F. / Webb, D. J. / Hayes, P. C. et al. | 2002
- 66
-
The role of the transjugular intrahepatic portosystemic stent-shunt(TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlationsTripathi, D. / Therapondos, G. / Jackson, E. / Redhead, D. N. / Hayes, P. C. et al. | 2002
- 66
-
Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantationSebekova, K. / Kupcova, V. / Schinzel, R. / Heidland, A. et al. | 2002
- 66
-
Profiling of gene expression changes of cirrhosis induced by telomere shortening in telomerase deficient miceWiemann, S. / Buhr, J. / Zipfel, B. / Manns, M. / Rudolph, L. et al. | 2002
- 66
-
Cytotoxic T-lymphocyte antigen 4 is associated with development and progression of alcoholic liver disease (ALD) in Italian patientsValenti, L. / De Feo, T. / Dongiovanni, P. / Fracanzani, A. / Fiorelli, G. / Fargion, S. R. et al. | 2002
- 67
-
The mechanism of improved sodium homeostasis of low-dose losartan in pre-ascitic cirrhosisWong, F. / Liu, P. / Blendis, L. et al. | 2002
- 67
-
Arterialisation of the portal vein improves hepatic parenchymal microcirculation in cirrhosis through stimulation of nitric oxideYang, W. / Koti, R. S. / Glantzounis, G. K. / Seifalian, A. M. / Davidson, B. R. et al. | 2002
- 67
-
The inductor of interferonogenesis amiksin in reducing of liver fibrosis and hepatic stellate cell activationAbdulchakov, S. / Sozinov, A. / Kiassov, A. et al. | 2002
- 67
-
Prognostic factors in the treatment of gastric or esophageal variceal bleeding with transjugular intrahepatic portosystemic shuntKim, Y. T. / Tak, W. Y. / Kweon, Y. O. / Kim, S. K. / Choi, Y. H. / Chung, J. M. et al. | 2002
- 68
-
The expression of cell cycle related proteins in rat hepatocytes is distinct from human hepatocytes when cultured in serum-free media supplemented with HGF (hepatocyte growth factor) and EGF (epidermal growth factor)Walldorf, J. / Koehler, C. / Cai, H. / Kleist, S. / Runge, D. / Strom, S. / Fleig, W. E. / Aurich, H. et al. | 2002
- 68
-
Expression of the chemokine CCL21 during chronic hepatitis C: potential role in inflammation and fibrosisBonacchi, A. / Petrai, I. / Romagnani, P. / Lazzeri, E. / Annunziato, F. / DeFranco, R. / Efsen, E. / Milani, S. / Pinzani, M. / Gentilini, P. et al. | 2002
- 68
-
Cholestasis induces shift of the short and long prolactin receptor (PRLR) MRNA isoform ratio in rat hepatocytesBogorad, R. / Rubtsov, P. / Smirnova, O. et al. | 2002
- 68
-
CD81 engagement by HCV envelope protein E2 mediates proMMP-2 synthesis and is associated with PI 4-kinase activation in human hepatic stellate cellsCappadona, S. / Mazzocca, A. / Rigamonti, C. / Carloni, V. / Abrignani, S. / Pinzani, M. et al. | 2002
- 69
-
TNF-alpha and TNF-alpha receptors serum levels do not correlate with gene expression of TNF-alpha and their receptors in the non-alcoholic steatohepatitis (NASH) patientsCayon, A. / Crespo, J. / Garcia-Unzueta, M. T. / Fernandez-Escalante, J. C. / Mayorga, M. / Fernandez-Gil, P. / Hernandez-Guerra, M. / Pons-Romero, F. et al. | 2002
- 69
-
Distinct pattern of biological effects on IFN signaling and cell transformation between HCC tumour and non-tumour cell-derived core proteinDelhem, N. / Sabile, A. / Giannini, C. / Moreau, M. / Brechot, C. et al. | 2002
- 69
-
TGF-beta down regulates factor VII gene promoter by inhibiting the binding of HNF-4De Lucas, S. / Bartolome, J. / Navacerrada, C. / Carreno, V. et al. | 2002
- 69
-
Role of transforming growth factor B (TGF-B) in hepatic fibrosis of non-alcoholic steatohepatitis (NASH) patientsCrespo, J. / Cayon, A. / Mayorga, M. / Dominguez-Diez, A. / Hernandez-Guerra, M. / Fernandez-Gil, P. / Pons-Romero, F. et al. | 2002
- 70
-
Inhibitory effect of insulin on cAMP response in hepatocytes: role of the phosphatidylinositol-3primekinase and of the transcription factor FKHRGroyer, G. / Cadepond, F. / Groyer, A. et al. | 2002
- 70
-
Cariporide, a selective Na+/H+ exchange inhibitor, decreases liver fibrosis in the bile duct ligated ratDi Sario, A. / Bendia, E. / Svegliati-Baroni, G. / Taffetani, S. / Ridolfi, F. / Schindler, U. / Kleemann, H. W. / Candelaresi, C. / Sterpetti, P. / Trozzi, L. et al. | 2002
- 70
-
C-kit (stem cell factor receptor) expression in normal and diseased adult human liverFurlanetto, A. / Togni, R. / Negri, S. / Colombari, R. et al. | 2002
- 70
-
NGF and Trk-A as a novel autocrine loop in the early stages of hepatic stellate cell (HSC) activationEfsen, E. / Bonacchi, A. / Petrai, I. / Rosini, P. / Torcia, M. / Pinzani, M. / Gentilini, P. / Marra, F. et al. | 2002
- 71
-
Prevalence of wild-type in interferon sensitivity determining region (ISDR) of hepatitis C virus in HIV-1 positive patients infected with HCV genotype 3A non responders to anti-HCV treatmentBagaglio, S. / Bruno, R. / De Bona, A. / Uberti-Foppa, C. / Finazzi, R. / Lazzarin, A. / Morsica, G. et al. | 2002
- 71
-
PPAR-beta and retinol metabolism related gene-expression in HSCHellemans, K. / Rombouts, K. / Michalik, L. / Wahli, W. / Geerts, A. et al. | 2002
- 71
-
Induction of the caspase 8 promoter after adenoviral infection, cisplatin treatment or application of ethanol depends on a functional P53 gene in human hepatoma cellsLiedtke, C. / Groger, N. / Manns, M. / Trautwein, C. et al. | 2002
- 71
-
Growth factor-induced survival pathways in activated human HSC: long-term dynamics and PI 3-K-independednt modulation of BAD phosphorylationGentilini, A. / DeFranco, R. M. / Lottini, B. / Meucci, M. / Foschi, M. / Gentilini, P. / Pinzani, M. et al. | 2002
- 72
-
Degradation of p27 is controlled by two sequential proteolytic pathways during G1 and S phase of the cell cycleMalek, N. / Sundberg, H. / Manns, M. / Roberts, J. et al. | 2002
- 72
-
Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in ratsSeo, M. Y. / Lee, S. M. et al. | 2002
- 72
-
Modulation of inducible nitric oxide synthase (ONSI) expression by inmunoferon in an endotoxemic model in ratsMajano, P. / Brieva, A. / Alonso-Levrero, J. L. / Pivel, J. P. / Moreno-Otero, R. et al. | 2002
- 72
-
Different expression of HIP/PAP transcripts in human hepatoma cellsCervello, M. / Giannitrapani, L. / La Rosa, M. / Notarbartolo, M. / D'Alessandro, N. / Virruso, L. / Iovanna, J. L. / Montalto, G. et al. | 2002
- 72
-
Identification of liver stem-like cells in human intrahepatic biliary epithelial cells (BEC) in vitroLiu, C. / Schreiter, T. / Dirsch, O. / Gerken, G. / Broelsch, C. E. / Treichel, U. et al. | 2002
- 73
-
Differential expression of Bcl-2 gene family induced by transforming growth factor beta1 (TGF-beta1) is regulated by ursodeoxycholate (UDC)Sola, S. / Laires, P. A. / Castro, R. E. / Ma, X. / Kren, B. T. / Steer, C. J. / Rodrigues, C. M. et al. | 2002
- 73
-
Oxidative stress down-regulates the expression of hydroxyacid oxidase 1, a liver-specific peroxisomal enzymeRecalcati, S. / Tacchini, L. / Conte, D. / Cairo, G. et al. | 2002
- 73
-
Expression profiling in liver cirrhosis and hepatocellular carcinoma (HCC) using a large scale real time RT-PCR approachParadis, V. / Bieche, I. / Dargere, D. / Laurendeau, I. / Bonvoust, F. / Olivi, M. / Nectoux, J. / Belghiti, J. / Degott, C. / Vidaud, M. et al. | 2002
- 73
-
Signalling for apoptosis and repair in vitroNeuman, M. / Katz, G. et al. | 2002
- 74
-
Ischemic preconditioning mediates protection through reversible burst of oxidative stress in miceRudiger, H. A. / Selzner, M. / Selzner, N. / Dindo, D. R. / Tian, Y. / Clavien, P. A. et al. | 2002
- 74
-
Tissue factor pathway inhibitor-2 is a new acute phase reactantHisaka, T. / Lamireau, T. / Maurel, P. / Kisiel, W. / Desmoulire, A. / Rosenbaum, J. et al. | 2002
- 74
-
Influence of nitric oxide donors on the sphingomyelinase activity,accumulation of lipid peroxidation products and DNA degradation in mice liverShupik, M. / Dudnik, L. / Vanin, A. / Alessenko, A. et al. | 2002
- 74
-
Hepatitis C virus proteins do not directly trigger fibrogenic events in human liver myofibroblastsTan, K. / Rosenbaum, J. et al. | 2002
- 75
-
5-lipoxygenase (5-LO) is involved in Kupffer cell survivalTitos, E. / Claria, J. / Planaguma, A. / Lopez-Parra, M. / Villamor, N. / Jimenez, W. / Arroyo, V. / Rivera, F. / Rodes, J. et al. | 2002
- 75
-
Cellular signalling during liver injury leading to hepatic fibrosis in vivoSvegliati-Baroni, G. / Ridolfi, F. / Taffetani, S. / Saccomanno, S. / Trozzi, L. / Caradonna, Z. / Folli, F. / Benedetti, A. et al. | 2002
- 75
-
Disruption of TGF-beta signal transduction in hepatocellular carcinoma by overexpression of Smad7Wiercinska, E. / Bauche, B. / Gressner, A. / Tannapfely, A. / Dooley, S. et al. | 2002
- 75
-
Antagonisation of the antiproliferative action of IFN-alpha on megacaryocytic cell lines by thrombopoietin (TPO)Weidekamm, C. / Kreil, A. / Pidlich, J. / Gangl, A. / Peck-Radosavljevic, M. / Wichlas, M. et al. | 2002
- 76
-
Survival benefit in hepatocellular carcinoma patients with portal vein tumor thrombosis treated by hepatic arterial infusion chemotherapyAndo, E. / Tanaka, M. / Yamashita, F. / Kuromatsu, R. / Sumie, S. / Fukumori, K. / Yutani, S. / Yano, Y. / Kumashiro, R. / Sata, M. et al. | 2002
- 76
-
Alpha adducin 1 Gly460Trp polymorphism affects the rate of fibrosis development in chronic hepatitis C virus infectionWright, M. / Goldin, R. / Hellier, S. / Hill, A. / Apple, R. / Cheng, S. / Thomas, H. / Thursz, M. et al. | 2002
- 76
-
4-Hydroxynonenal selectively up-regulates timp-1 gene expression inhuman hepatic stellate cellsZamara, E. / Novo, E. / Robino, G. / Caligiuri, A. / Pizzimenti, S. / Laurora, S. / Pinzani, M. / Dianzani, M. U. / Parola, M. et al. | 2002
- 76
-
Development of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-related cirrhosisAkarca, U. S. / Lebe, E. / Karasu, Z. / Gunsar, F. / Ersoz, G. / Batur, Y. et al. | 2002
- 77
-
The vagal nerve stimulates growth of the human and rat hepatic progenitor cell compartment, via muscarinic acetylcholine receptor 3Cassiman, D. / Libbrecht, L. / Sinelli, N. / Desmet, V. / Denef, C. / Roskams, T. et al. | 2002
- 77
-
Alteration of human DNA repair enzymes hMTH1, hOGG1 and hMYH mRNA expression with respect to 8-hydroxy-2-deoxyguanosine DNA adduct levels in hepatocellular carcinomaCheng, B. / Juengst, C. / Nischalke, H. D. / Schirmacher, P. / Sauerbruch, T. / Caselmann, W. H. et al. | 2002
- 77
-
Retinoic acid receptor-selective ligands and hepatocellular carcinoma (HCC)Rana, B. / Redfern, C. / Manas, D. / Bassendine, M. et al. | 2002
- 78
-
Is tumor size the only factor that determines the efficacy of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC)?Di Costanzo, G. G. / de Luca, M. / Ascione, A. et al. | 2002
- 78
-
Dendritic cell function in patients with hepatocellular carcinomaDaniels, H. / Hannoe, J. / Costelloe, S. / Patel, V. / Farzaneh, F. / Harrison, P. et al. | 2002
- 78
-
Royal free (RFH) scoring system for unifocal hepatocellular carcinoma(HCC) <5 cm diameter: a valuable prognostic toolColombari, R. / Togni, R. / Furlanetto, A. / Quaglia, A. / Dhillon, A. / Demichelis, F. / Spinoso, A. / Capelli, P. / Marchiori, L. / Nicoli, N. et al. | 2002
- 78
-
Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanismSindram, D. / Rudiger, H. A. / Upadhya, A. G. / Strasberg, S. M. / Clavien, P. A. et al. | 2002
- 78
-
HIP/PAP a C-type lectin overexpressed in hepatocellular carcinomabinds the RII alpha regulatory subunit of PKADemaugre, F. / Philippe, Y. / Pileire, B. / Sar, S. / Christa, L. / Brechot, C. et al. | 2002
- 79
-
The role of TGF-beta in liver regeneration: studies with CRP/TGF-beta transgenic miceGarcia-Lazaro, J. F. / Meyer, E. / Brauer, S. / Lueth, S. / Balderas, I. / Galle, P. R. / Lohse, A. W. / Kanzler, S. et al. | 2002
- 79
-
Adenovirus-mediated gene transfer of VEGF and endostatin influences liver regeneration in miceRedaelli, C. / Sauter, B. / Ledermann, M. / Schmidt, K. / Dufour, J. F. et al. | 2002
- 79
-
NF-kB activation is involved on PGE1 protection against D-galactosamine-induced apoptosis in primary culture of rat hepatocytesFouad, D. / Siendones, E. / Montero, J. L. / De la Mata, M. / Muntane, J. / Mino, G. et al. | 2002
- 79
-
Estrogen receptors and oxidative damage in the liverFarinati, F. / Cardin, R. / Bortolami, M. / Grottola, A. / Manno, M. / Colantoni, A. / Villa, E. et al. | 2002
- 80
-
Prevalence of a 660 amino acid substitution in the PePHD region of HCV-E2 protein in hepatocellular carcinomaMorsica, G. / Bagaglio, S. / Alberti, A. / Lazzarin, A. / Bernardi, M. / de Mitri, M. S. et al. | 2002
- 80
-
Comparative analysis of the survival rate of patients with HCC by schedule of taceKim, S. J. / Park, C. H. / Joo, Y. E. / Choi, S. K. / Rew, J. S. / Kim, J. K. et al. | 2002
- 80
-
Hereditary causes of hepatocellular carcinoma in a Swedish populationHoffmann, G. / Lindgren, S. / Verbaan, H. / Hallden, C. / Carlson, J. et al. | 2002
- 80
-
HCC and liver transplantation (LT): risk factors for recurrenceGrasso, A. / Quaglia, A. / Montalto, P. / Dhillon, A. P. / Patch, D. / Davidson, B. / Rolles, K. / Tibbals, J. / Watkinson, A. / Babar, S. et al. | 2002
- 81
-
Massive liver growth induced by interleukin-6 overexpression in miceZimmers, T. / McKillop, I. / Pierce, R. / Yoo, J. Y. / Murtha-Riel, P. / Koniaris, L. et al. | 2002
- 81
-
The Anti-apoptotic and pro-proliferative p53-related DN-p73 protein is expressed in human HCCPalescandolo, E. / Costanzo, A. / Vossio, S. / Pediconi, N. / Merlo, P. / Almerighi, C. / Fulco, M. / Cariani, E. / Balsano, C. / Levrero, M. et al. | 2002
- 81
-
Tumor doubling time and vascularity predict prognosis of patients with small hepatocellular carcinoma in JapanKuromatsu, R. / Tanaka, M. / Ando, E. / Sata, M. et al. | 2002
- 81
-
HGF modifies but does not inhibit the hepatocarcinogenesis induced by diethylnitrosamine in transgenic mouse modelsKiss, A. / Factor, V. / Novak, P. K. / Conner, E. / Schaff, Z. / Thorgeirsson, S. et al. | 2002
- 82
-
Doxorubicin-loaded nanoparticles shows increased cytotoxicity efficacy agains hepatocellular carcinoma cells in vitro and in vivoBarraud, L. / Merle, P. / Soma, E. / Lefrancois, L. / Guerret, S. / Chevallier, M. / Dubernet, C. / Couvreur, P. / Trepo, C. / Vitvitski, L. et al. | 2002
- 82
-
Thrombopoietin stimulates migration and invasion of HepG2 cellsPetrai, I. / Romanelli, R. G. / Bonacchi, A. / Efsen, E. / Pagliai, G. / Grossi, A. / Gentilini, P. / Laffi, G. / Marra, F. et al. | 2002
- 82
-
CD34, VEGF expression and hepatitis virus typeOhmori, S. / Shiraki, K. / Inoue, H. / Okano, H. / Yamanaka, T. / Deguchi, M. / Sakai, T. / Nakano, T. et al. | 2002
- 82
-
PPAR-gamma augments death receptor signaling in hepatocellularcarcinomaOkano, H. / Shiraki, K. / Inoue, H. / Deguchi, M. / Sugimoto, K. / Sakai, T. / Ohmori, S. / Murata, K. / Nakano, T. et al. | 2002
- 83
-
Surface expression of squamous cell carcinoma antigen (SCCA) variant can be upregulated by pre-S1(21-47) sequence of HBVRuvoletto, M. / Marino, M. / Tono, N. / Gatta, A. / Fassina, G. / Pontisso, P. et al. | 2002
- 83
-
Clonality and genomic heterogeneity in HCC and putative precursor nodular lesionsQuaglia, A. / Laurent, C. / Girlando, S. / Saini, J. / Palma, P. D. / Colombari, R. / Bioulac-Sage, P. / Balabaud, C. / Davidson, B. / Togni, R. et al. | 2002
- 83
-
Constitutively active TGF-beta-receptors restore TGF-beta signaling in HuH7 cellsRabe, C. / Paik, M. / Berna, M. / Schmitz, V. / Sauerbruch, T. / Caselmann, W. H. et al. | 2002
- 83
-
Cellular gene activation by HBV integration in or close to chromosomal regulative elements: a hypothesis from the WHV/woodchuck modelBruni, R. / Villano, U. / D'Ugo, E. / Giuseppetti, R. / Argentini, C. / Rapicetta, M. et al. | 2002
- 84
-
Alcohol dehydrogenase 31 genotype is associated with alcohol-related hepatocellular carcinomaStickel, F. / Benesova, M. / Schuppan, D. / Homann, N. / Hahn, E. G. / Seitz, H. K. et al. | 2002
- 84
-
Study of hepatitis B virus X protein (HBx) mutants and quantification of HBV-DNA in tumorous and non-tumorous hepatocytes using laser capture microdissection (LCM)Iavarone, M. / Trabut, J. B. / Carnot, F. / Kremsdorf, D. / Brechot, C. / Thiers, V. et al. | 2002
- 84
-
Identification of differentially expressed genes in hepatocellular carcinoma using representational difference analysisTak, W. Y. / Min, C. / Kweon, Y. O. / Kim, S. K. / Choi, Y. H. / Chung, J. M. / Sung, Y. K. / Kim, J. C. / Kim, M. K. et al. | 2002
- 84
-
Identification of somatostatin receptors in human cirrhosis and hepatocellular carcinomaReynaert, H. / Rombouts, K. / Hellemans, K. / Vandermonde, A. / Lazou, J. M. / Urbain, D. / Bioulac-Sage, P. / Rosenbaum, J. / Geerts, A. et al. | 2002
- 85
-
Induction of apoptosis via mitogen-activated protein kinase pathway by a K vitamin analog in rat hepatocytesWang, Z. / Nishikawa, Y. / Wang, M. / Carr, B. I. et al. | 2002
- 85
-
The immune privilege by trail expression in hepatocellular carcinoma cellsYamanaka, T. / Shiraki, K. / Inoue, H. / Okano, H. / Deguchi, M. / Sakai, T. / Ohmori, S. / Fujikawa, K. / Nakano, T. et al. | 2002
- 85
-
Surveillance for hepatocellular carcinoma in elderly cirrhotic patients. Effects on cancer staging and patient survivalTrevisani, F. / De Notariis, S. / Cantarini, M. C. / Rapaccini, G. / Farinati, F. / Benvegnu, L. / Zoli, M. / Del Poggio, P. / Di Nolfo, M. A. / Bernardi, M. et al. | 2002
- 85
-
Signaling through the keratinocyte growth factor receptor is essential for liver regeneration but not liver developmentWuestefeld, T. / Steiling, H. / Kubicka, S. / Gordon, J. I. / Manns, M. P. / Werner, S. / Trautwein, C. et al. | 2002
- 85
-
Gene therapy by intercellular trafficking of p53-VP22 induces regression of orthotopic hepatocellular carcinoma in ratsZender, L. / Hutker, S. / Frericks, B. / Eckhard, M. / Gosling, T. / Galanski, M. / Krettek, C. / Kuhnel, F. / Manns, M. / Kubicka, S. et al. | 2002
- 86
-
IFN system activation in liver from naive HCV chronic patientsAbbate, I. / Romano, M. / Longo, R. / Cappiello, G. / Lo Iacono, O. / Di Marco, V. / Ursitti, A. / Spano, A. / Capobianchi, M. R. et al. | 2002
- 86
-
Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapyAkkiz, H. / Ergun, Y. / Colakoglu, S. / Sandikci, M. / Serin, M. / Bekar, A. / Oksuz, M. / Isiksal, F. / Kocak, F. / Abayli, B. et al. | 2002
- 86
-
Single hepatocellular carcinomas larger than 4 CM mainly occur in the right liver lobe in the absence of cirrhosis or viral diseaseZuckermann, M. / Cetta, F. / Del Vecchio, M. T. / Pergola, L. / Piccini, M. / Dell'Avanzato, R. / De Martino, A. / Ercolani, G. / Mazziotti, A. et al. | 2002
- 87
-
Lamivudine treatment enhances allostimulatory function of HBV-infected dendritic cells in vitroBeckebaum, S. / Cicinnati, V. / Zhang, X. / Achterfeld, A. / Stolz, D. / Frilling, A. / Broelsch, C. E. / Gerken, G. et al. | 2002
- 87
-
Yellow fever vaccination is associated with false-positive serology to hepatitis C virusBassetti-Soares, E. / Pereira, E. M. / Souza, M. E. / Teixeira, R. et al. | 2002
- 87
-
Characterization of HCV RNA particles from the serum of a patient with common variable immunodeficiency on isotonic iodixanol (OPTIPREP) gradients. Association with apolipoprotein-B100Nielsen, S. / Pumeechockchai, W. / Burt, A. / Bassendine, M. / Toms, G. et al. | 2002
- 87
-
Characterization of the structural proteins of HCV isolated from human liverNielsen, S. / Bassendine, M. / Burt, A. / Toms, G. et al. | 2002
- 88
-
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathwaysCaini, P. / Giannini, C. / Giannelli, F. / Brechot, C. / Zignego, A. L. et al. | 2002
- 88
-
The role of thymic output in reversal of T cell hypo-responsiveness in chronic hepatitis B virus (HBV) infectionMathou, N. / Webster, G. / Gotto, J. / Brown, D. / Dusheiko, G. et al. | 2002
- 88
-
The purine nucleotide analogue LY582563 (mcc-478) inhibits replication of wild type and drug resistant hepatitis b virusColledge, D. / Shaw, T. / Bowden, S. / Locarnini, S. / Lewin, S. / Wightman, F. / Colacino, J. et al. | 2002
- 88
-
Early detection and monitoring of variants resistant to lamivudine using inno-lipa HBV-DR in chronic hepatitis BButi, M. / Valdes, A. / Cotrina, M. / Jardi, R. / Rodriguez-Frias, F. / Costa, X. / Esteban, R. / Guardia, J. et al. | 2002
- 89
-
Hepatic iron distribution in 153 patients with chronic viral hepatitis (CH): relation with grading, staging and HFE mutationsCorengia, C. / Bovo, G. / Arosio, C. / Chiesara, A. / Salvioni, A. / Mauri, V. / Pozzi, M. / Cestari, C. / Vergani, A. / Piperno, A. et al. | 2002
- 89
-
Ultrastructural hepatocyte modifications in HCV infected human liverFalasca, L. / Ciccosanti, F. / Nardacci, R. / Lo Iacono, O. / Piacentini, M. et al. | 2002
- 89
-
HBV genotyping analysis from the surface antigen region using the trugene HBV genotyping kit and a PCR-based homebrew methodHuong, J. / Reece, K. / Grunwald, A. / Sturchio, C. / De La Rosa, A. / Healy, M. et al. | 2002
- 89
-
Lamivudine-resistant HBV is cross-resistant to L-dT and L-dC in vitroDelaney, W. / Yang, H. / Miller, M. / Gibbs, C. / Xiong, S. et al. | 2002
- 89
-
Different modulation of PKR gene expression by HCV genotypesGerotto, M. / Dal Pero, F. / Boccato, S. / Bortoletto, G. / Ferrari, A. / Realdon, S. / Alberti, A. et al. | 2002
- 90
-
Ortho total HCV core antigen assay can aid early prediction of response in patients treated with interferon/ribavirinLunel, F. / Veillon, P. / Payan, C. et al. | 2002
- 90
-
Apoptosis of peripheral blood lymphocytes in chronic viral hepatitis CBoueverov, A. / Choulpekova, I. / Maevskaya, M. / Vashkin, V. / Mammaev, S. et al. | 2002
- 90
-
Quantitative determination of hepatitis C virus core antigen (HCVAg) and prediction of response to therapy in chronic HCV infectionJacobs, R. / Brown, D. / Diment, J. / Whitehe, J. / Dusheiko, G. et al. | 2002
- 90
-
Evaluation of ortho total HCV core antigen assay in assessment and follow up of patients treated for chronic HCVLunel, F. / Veillon, P. / Payan, C. et al. | 2002
- 91
-
IFN-gamma production in response to HCV proteins in chronic versus acute phase of HCV-infectionNisii, C. / D'Offizi, G. / Lo Iacono, O. / Antonucci, G. / Ippolito, G. / Oliva, A. et al. | 2002
- 91
-
Infected hepatocytes are selectively eliminated by trail in viral hepatitisMundt, B. / Walthemate, M. / Kuhnel, F. / Zender, L. / Paul, Y. / Tillmann, H. L. / Trautwein, C. / Manns, M. / Kubicka, S. et al. | 2002
- 91
-
Effector/memory cell dynamics in peripheral blood and liver compartments of chronically HCV-infected patientsNisii, C. / Poccia, F. / D'Offizi, G. / Lo Iacono, O. / Antonucci, G. / Ippolito, G. / Oliva, A. et al. | 2002
- 91
-
Tissue transglutaminase in hepatitis C pathogenesisNardacci, R. / Ciccosanti, F. / Falasca, L. / Amendola, A. / Addesso, M. / Ruco, L. / Fimia, G. M. / Antonucci, G. / Ippolito, G. / Craxi, A. et al. | 2002
- 92
-
Molecular analyses of TT virus in paired serum and tissue samples from 150 patients with either hepatic or non-hepatic diseasePollicino, T. / Raffa, G. / Squadrito, G. / Cacciola, I. / Brancatelli, S. / Alafaci, C. / Florio, M. G. / Raimondo, G. et al. | 2002
- 92
-
Genetic variability of E1/E2 regions of HCV genotype 4Argentini, C. / Dettori, S. / Di Paola, D. / Gandin, C. / Angelico, M. / Rapicetta, M. et al. | 2002
- 92
-
Decreased peripheral blood CD19+ B-cell apoptosis, activation of nuclear factor-kappaB and immunoglobulin gene heavy chain (IgH) rearrangement in hepatitis C virus (HCV) infection: mechanisms for lymphomagenesis?Par, A. / Szereday, L. / Gasztonyi, B. / Kiss, K. / Kereskai, L. / Szomor, A. / Par, G. / Szeberenyi, J. / Pajor, L. / Szekeres-Bartho, J. et al. | 2002
- 92
-
Demonstration of HCV replication in eccrine sweat glandsOrtiz-Movilla, N. / Rodriguez-Inigo, E. / Bartolome, J. / Pardo, M. / Lazaro, P. / Longo, I. / Carreno, V. et al. | 2002
- 93
-
ISRE-independent inhibition of HBV-enhancer I, II and core promoter regulated transcription by type I interferonsSeidler, B. / Freilinger, T. / Burkard, I. / Erfle, V. / Schulte-Frohlinde, E. et al. | 2002
- 93
-
CXC and CC chemokines in liver tissue in HCV patients: IP-10 expression correlates with liver disease activityRico, M. A. / Ruiz, S. / Quiroga, J. A. / Pardo, M. / Carreno, V. et al. | 2002
- 93
-
Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timingVeldt, B. J. / Laine, F. / Guillygomarc'h, A. / Lauvin, L. / Boudjema, K. / Messner, M. / Brissot, P. / Deugnier, Y. / Moirand, R. et al. | 2002
- 93
-
p21 expression and hepatitis virus typeShiraki, K. / Wagayama, H. / Inoue, H. / Okano, H. / Deguchi, M. / Yamanaka, T. / Sakai, T. / Ohmori, S. / Nakano, T. et al. | 2002
- 93
-
Hepatitis C virus non-structural (NS)5A protein and interferon resistance: challenge of simple mutational analyses by a new bio-mathematical modelSarrazin, C. / Herrmann, E. / Bruch, K. / Zeuzem, S. et al. | 2002
- 94
-
Selection of a secretion defective HBV strain as the predominant viral strain in a patient with severe recurrence of HBV after liver transplantationSterneck, M. / Kalinina, T. / Fischer, L. / Riu-Garcia, A. / Will, H. et al. | 2002
- 94
-
Histopathological and immunohistochemical features of acute type C hepatitisWalewska-Zielecka, B. / Kryczka, W. / Ceglarek, B. / Gietka, A. / Wyzgal, J. et al. | 2002
- 94
-
A viral kinetic study using pegylated interferon alpha 2b and lamivudine in naive patients with HBeAg(-)/I-BV-DNA(+) chronic hepatitis B: preliminary resultsSypsa, V. / Tassopoulos, N. C. / Chrysagis, D. / Mimidis, K. / Vassiliadis, T. / Raptopoulou, M. / Ketikoglou, I. / Haida, C. / Paraskevis, D. / Lafleur, F. et al. | 2002
- 94
-
Prevalence of histologic lesions compatible with alcohol intake (LCAI) in chronic hepatitis C (CHC) patientsTrapero, M. / Marugan, M. T. / Monteagudo, J. A. / Buey, L. G. / Borque, M. J. / Sanchez, A. G. / Otero, R. M. et al. | 2002
- 95
-
The effect of anti-viral treatment on peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus (HCV) infectionZuckerman, E. / Kessel, A. / Slobodin, G. / Sabo, E. / Yeshurun, D. / Toubi, E. et al. | 2002
- 95
-
Relationship between HBV core-promoter sequences and selection of lamivudine resistant mutants in CHBe antigen-negative patientsAbate, M. M. / Paganin, S. / Barbon, V. / Lagget, M. / Niro, G. / Olivero, A. / Smedile, A. / Rizzetto, M. et al. | 2002
- 95
-
Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus (HCV) infection: association with liver disease severityZuckerman, E. / Kessel, A. / Slobodin, G. / Goldstein, L. / Sabo, E. / Yeshurun, D. / Toubi, E. et al. | 2002
- 95
-
Evolution of hepatitis B virus during primary infection: relevance to virulence and outcomeWhalley, S. / Brown, D. / Webster, G. / Jacobs, R. / Teo, C. G. / Emery, V. / Dusheiko, G. et al. | 2002
- 96
-
Precore chronic HBV hepatitis - clinical and histological correlationsDitoiu, A. V. / Motoi, O. / Teiusan, A. / Simion, L. / Voiculescu, M. et al. | 2002
- 96
-
Questioning the sustained response to the interferon therapy in HBeAg(-) chronic hepatitis BAkarca, U. S. / Lebe, E. / Ersoz, G. / Gunsar, F. / Karasu, Z. / Kilincsoy, N. / Celebi, A. / Batur, Y. et al. | 2002
- 96
-
Sustained response to the interferon therapy in HBeAg(+) chronic hepatitis B is not sustainedAkarca, U. S. / Lebe, E. / Gunsar, F. / Karasu, Z. / Kilincsoy, N. / Ersoz, G. / Celebi, A. / Batur, Y. et al. | 2002
- 96
-
Metabolic cofactors play an important role in fibrosis progression in initially mild chronic hepatitis CAlberti, A. / Vario, A. / Boccato, S. / Ferrari, A. / Benvegnu, L. / Gatta, A. et al. | 2002
- 97
-
Evaluation of dry incubators instead of circulating water baths relative to its use in the versanttm HCV RNA qualitative assay (TMA)Beld, M. / Gall-Lemagne, C. / Rebers, S. / Sluimer, H. / Hunt, W. et al. | 2002
- 97
-
Interferon therapy in chronic hepatitis C virus infection does not modify evolutionary course of viral quasispecies in nonrespondersMarugan, R. B. / Garcia, J. M. / Del Campo, T. S. / Rubio, M. G. et al. | 2002
- 97
-
Comparison between leukocyte interferon alpha plus ribavirin and R-alpha2B interferon plus ribavirin for treatment of CHC in naive patients: a multicenter randomized Italian studyBarbarini, G. / Barbaro, G. / Pellicelli, A. / Fruttaldo, L. / Bacca, D. / Babudieri, S. / Torre, D. / Rizzo, G. / Francavilla, R. / Annese, M. et al. | 2002
- 97
-
Orthotopic liver transplantation does not modify complexity of viral quasispecies of hepatitis C virus: single stranded conformational polymorfism (SSCP) analysisGarcia, J. M. / Del Campo, T. S. / Rubio, M. G. / Marugan, R. B. et al. | 2002
- 98
-
Relationship between hepatitis B virus (HBV) genotype and the precore mutant in anti-HBe(+) patients before and after liver transplantation (LT)Ben-Ari, Z. / Ashur, Y. / Daudi, N. / Wiess, H. / Sulkes, J. et al. | 2002
- 98
-
Long term follow up of thalassemic patients with hepatitis C and normal aminotransferases treated with interferon-alphaBerdoussi, H. / Manolaki, A. / Kostaridou, S. / Ladis, V. / Nakopoulou, L. / Kattamis, C. et al. | 2002
- 98
-
Comparison between IFNalpha2a + ribavirin and IFNalpha2a + amantadine combination therapy in naive patients with chronic hepatitis C-genotype 1, and between amantadine and ribavirin addition in non responders after 3 monthsBellobuono, A. / Finazzi, R. / Covini, G. / Milazzo, L. / Magni, C. / Milella, A. M. / Janoletti, C. / Bozzetti, F. / Ideo, G. et al. | 2002
- 99
-
A triple therapy of interferon alfa-2a, ribavirin and amantadine for chronic hepatitis C patients now responders to standard therapy: interim analysis of a large Belgian cohortBourgeois, N. / Van Der Meeren, O. et al. | 2002
- 99
-
Vitamin E does not reduce ribavirin associated anaemia during combination therapy for hepatitis CBoccato, S. / Ferrari, A. / Gatta, A. / Alberti, A. et al. | 2002
- 99
-
The effect of hepatectomy on glucose homeostasis in pig and in manLauritsen, T. L. / Grunnet, N. / Rasmussen, A. / Secher, N. H. / Quistorff, B. et al. | 2002
- 99
-
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapyBerg, T. / Sarrazin, C. / Gerlach, T. / Hinrichsen, H. / Zachoval, R. / Hopf, U. / Zeuzem, S. et al. | 2002
- 100
-
Adefovir dipivoxil safety and pharmacokinetics in subjects with hepatitis B virus infection and in healthy subjectsKearney, B. / Knight, W. / Currie, G. / Beutelspacher, D. / Ebrahimi, R. / Gill, S. / Fry, J. / Brosgart, C. et al. | 2002
- 100
-
Efficacy of a short-schedule/high dose hepatitis B vaccination in drug usersBrissette, S. / Gomez, M. / Lambert, J. / Willems, B. et al. | 2002
- 100
-
A drug-drug interaction study between adefovir dipivoxil and lamivudine, acetaminophen, ibuprofen and trimethoprim/sulfamethoxazoleKearney, B. / Knight, W. / Currie, G. / Contreras, J. / Wolf, J. / Gill, S. / Fry, J. / Brosgart, C. et al. | 2002
- 100
-
Lamivudine is not effective in the treatment of non-cirrhotic HBeAg (-) chronic hepatitis B patients with low level viremiaBozkaya, H. / Yurdaydin, C. / Bozdayi, M. / Sagiroglu, A. K. / Erkan, O. / Uzunalimoglu, O. et al. | 2002
- 101
-
Renal function and ribavirin dosing in chronic hepatitis CBruchfeld, A. / Lindahl, K. / Schvarcz, R. / Stahle, L. et al. | 2002
- 101
-
Three years of lamivudine in anti-HBe positive patients decreased virological and biochemical responseRuiz, L. / Valdes, A. / Cotrina, M. / Jardi, R. / Rodriguez-Frias, F. / Costa, X. / Esteban, R. / Guardia, J. / Buti, M. et al. | 2002
- 101
-
Is Peg-interferon plus ribavirin a cost-effective therapy, and if so, what is the most efficient way to use this therapy in naive patients with chronic hepatitis C?Buti, M. / Casado, M. A. / Medina, M. / Fosbrook, L. / Esteban, R. et al. | 2002
- 101
-
Impact of methadone treatment on the outcome of combination therapy for hepatitis CBuggisch, P. / Wursthorn, K. / Ullmann, R. / Seegers, B. / Greten, H. et al. | 2002
- 102
-
Clinical significance of alt flares in patients with chronic hepatitis B treated with lamivudineButi, M. / Valdes, A. / Cotrina, M. / Jardi, R. / Rodriguez-Frias, F. / Esteban, R. / Guardia, J. et al. | 2002
- 102
-
Steatosis evolution is a main determinant of fibrosis progression in untreated patients with chronic hepatitis CCastera, L. / Hezode, C. / Roudot-Thoraval, F. / Bastie, A. / Zafrani, E. S. / Pawlotsky, J. M. / Dhumeaux, D. et al. | 2002
- 102
-
Two doses of PEG-interferon alfa-2b plus rivabirin in genotype 1 naive patients with chronic hepatitisButi, M. / Lurie, Y. / Sanchez, F. / Valdes, A. / Martell, M. / Esteban, R. / Guardia, J. et al. | 2002
- 102
-
Differentiation of HCV quasispecies under therapy: is it important in determining viral clearance?Cappiello, G. / Abbate, I. / Lo Iacono, O. / Capobianchi, M. R. / Longo, R. / Solmone, M. / Ferraro, D. / Antonucci, G. / Di Marco, V. / Craxi, A. et al. | 2002
- 103
-
Occult HBV infections worsen the course of hepatitis infectionChemin, I. / Scoazec, G. B. / Bonnaventure, P. / Chevallier, M. / Chevallier, P. / Merle, P. / Zoulim, F. / Trepo, C. et al. | 2002
- 103
-
YMDD motif mutant occurs as a spontaneous viral genome variability in patients with chronic hepatitis B virus infectionCho, M. / Heo, J. / Shin, Y. M. / Kim, G. H. / Chu, H. J. / Kang, D. H. / Song, G. A. / Yang, U. S. / Kim, C. M. / Jang, H. J. et al. | 2002
- 103
-
Detection of HCV-RNA in saliva of patients with chronic hepatitis C virus infectionCastro, A. / Hermida, M. / Barral, S. / Ferreiro, M. C. / Laredo, R. / Diz, P. / Lopez, S. / Pedreira, J. et al. | 2002
- 103
-
Is sustained virologic response durable in patients with chronic hepatitis C treated with interferon alfa with or without ribavirin?Cheinquer, N. / Cheinquer, H. / Coelho-Borges, S. et al. | 2002
- 104
-
Contrast-enhanced sonography of the liver: introducting a systematic approach for lesion detection and characterizationCorreas, J. M. / Jrad, Z. / Fontaine, H. / Pol, S. / Helenon, O. et al. | 2002
- 104
-
Predictive value of ALT and HBV DNA levels in response to sequential combination treatment of lamivudine and interferon in HBeAg-/ANTI-Hbe+ chronic hepatitis BCinar, K. / Sarioglu, M. / Cetinkaya, H. / Bozdayi, M. / Uzunalimoglu, O. / Yurdaydin, C. / Bozkaya, H. et al. | 2002
- 104
-
The early decrease of hepatitis C virus core antigen in the serum of chronic hepatitis C patients predicts drug efficacy and primary response to antiviral therapyCoco, B. / Moscato, G. A. / Oliveri, F. / Colombatto, P. / Ciccorossi, P. / Maina, A. / Tackney, C. / Bonino, F. / Brunetto, M. R. et al. | 2002
- 105
-
High prevalence of helicobacter pylori in an Israeli ethnically heterogeneous hepatitis C population: innocent bystander or more?Delpre, G. / Niv, Y. et al. | 2002
- 105
-
Chronic hepatitis C (CHC) does not impair the physiologic increase of erythropoietin (EPO) production in response to the ribavirin (RBV)-induced anemiaMangoni, E. D. / Adinolfi, L. E. / Tripodi, M. F. / Marrone, A. / Saviano, D. / Giordano, M. / Ruggiero, G. et al. | 2002
- 105
-
Distribution and clinical response of HBV genotypes in phase III studies of adefovir dipivoxilWestland, C. / Delaney, W. / Ynag, H. / Fry, J. / Brosgart, C. / Gibbs, C. / Miller, M. / Xiong, S. et al. | 2002
- 105
-
Impact of smoker's polycythemia on clinical and laboratory features and on the response rate to interferon-alpha in chronic hepatitis C (CHC) patientsEl-Zayadi, A. R. / Selim, O. / Hamdy, H. / El-Tawil, A. / Mostapha, H. et al. | 2002
- 105
-
The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replicationSobao, Y. / Tomiyama, H. / Sugi, K. / Tokunaga, M. / Ueno, T. / Saito, S. / Fujiyama, S. / Morimoto, M. / Tanaka, K. / Takiguchi, M. et al. | 2002
- 106
-
Diagnostic value of liver biopsy in patients with chronic hepatitis C infectionFabre, A. / Main, J. / Thomas, H. / Foster, G. / Goldin, R. et al. | 2002
- 106
-
Antiviral monotherapy and combination therapy for patients with hepatitis B virus (HBV) infection after liver transplantation (LTX)Fischer, L. / Sterneck, M. / Meier, D. / Zoellner, B. / Rogiers, X. et al. | 2002
- 106
-
Long-term persistence of anti-HBs after vaccination against HBV: a 18 year experienceBaldo, V. / Floreani, A. / Renzulli, G. / Cristofoletti, M. / Trivello, R. et al. | 2002
- 106
-
Decreased bone mineral density in noncirrhotic patients with chronic hepatitis B or CSchiefke, I. / Borte, G. / Wiese, M. / Schenker, E. / Fach, A. et al. | 2002
- 107
-
Viral kinetics of combination pegylated interferon a-2a and ribavirin in patients with hepatitis C cirrhosisGane, E. / Chapman, B. / Holland, J. / Duxfield, J. / Shi, G. / Cornelius, D. / Bain, H. et al. | 2002
- 107
-
Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in HIV-infected patientsRomero, M. / Perez-Olmeda, M. / Garcia-Samaniego, J. / Gonzalez, J. / Castro, A. / Arribas, J. R. / Pedreira, J. / Soriano, V. et al. | 2002
- 107
-
Lamivudine in anti-HBe positive chronic hepatitis: clinical outcomeAscione, T. / Utech, W. / Macri, M. / Ascione, A. / Lanza, A. G. et al. | 2002
- 108
-
Hepatitis C virus prevalence among general population and risk groups in the Slovak RepublicGazdik, F. / Pijak, M. / Kazar, J. / Kuba, D. / Laktis, K. / Gazdikova, K. et al. | 2002
- 108
-
Efficacy and safety of combination therapy with interferon plus ribavirin in HIV-infected patients with chronic hepatitis CPerez-Olmeda, M. / Asensi, V. / Romero, M. / Sanchez-Montero, F. / Santin, M. / Ochoa, A. / Guardiola, J. / Blanch, J. / Garcia-Samaniego, J. / Soriano, V. et al. | 2002
- 108
-
Hepatitis C and diabetes mellitus: what is the connection?Garrido, A. / Guerrero, F. J. / Lepe, J. A. / Palomo, S. / Grilo, A. et al. | 2002
- 109
-
Single nucleotide polymorphism in tumor necrosis factor promoter: association with disease progression in hepatitis C virus infectionGoyal, A. / Kazim, S. N. / Parvez, M. K. / Wakil, S. / Arora, N. / Sarin, S. K. et al. | 2002
- 109
-
Interferon alpha-2b alone or combined with recombinant granulocyte-macrophage colony-stimulating factor as treatment of chronic hepatitis CGroenbaek, K. / Krarup, H. / Ring-Larsen, H. / de Muckadell, O. S. / Moeller, A. / Schlicting, P. / Vyberg, M. et al. | 2002
- 109
-
Mononuclear cells cytokines and interferonotherapy results prognosing in chronic viral hepatitisGeyvandova, N. / Yagoda, A. et al. | 2002
- 109
-
HCV infection screening and treatment in drug users followed in an addiction out patient unitGrando, V. / Goisset, P. / Sorge, F. / Trinchet, J. C. / Castera, L. / Roulot, D. / Sitruk, V. / Beaugrand, M. et al. | 2002
- 110
-
Concordance between anti HCV and HCV RNA among patients with and without biochemical evidence of liver diseaseHazari, S. / Panda, S. / Acharya, S. et al. | 2002
- 110
-
Inequalities in access to healthcare of hepatitis C patients in a general populationHatem, C. / Minello, A. / Gossard, A. C. / Jooste, V. / Evrard, P. / Obert, B. / Rassiat, E. / Milan, C. / Monnet, E. / Miguet, J. P. et al. | 2002
- 110
-
QOL benefits observed as early as week 2 with peginterferon alfa-2a (40KD) (PEGASYS) in combination with ribavirin (RBV) versus interferon alfa-2b plus RBVHassanien, T. I. / Cooksley, W. G. / Sulkowski, M. / Smith, C. / Marinos, G. / Lai, M. Y. / Pastore, G. / Trejo-Estrada, R. / Horta, A. / Vale, E. et al. | 2002
- 110
-
Sustained antiviral response and lack of viral resistance with long term adefovir dipivoxil (ADV) therapy in chronic HBV infectionHeathcote, E. / Jeffers, L. / Perrillo, R. / Wright, T. / Sherman, M. / Namini, H. / Xiong, S. / James, C. / Ho, V. / Fry, J. et al. | 2002
- 111
-
Predictive markers of therapy outcome in chronic hepatitis CIacob, S. / Iacob, R. / Diculescu, M. et al. | 2002
- 111
-
Factors associated with steatosis and relationship between steatosis and the severety of the disease in patients with chronic hepatitis CHezode, C. / Roudot-Thoraval, F. / Bralet, M. P. / Mallat, A. / Pawlotsky, J. M. / Zafrani, E. S. / Dhumeaux, D. et al. | 2002
- 111
-
Predictive value of twenty-four-hour quantification in interferon therapy of chronic hepatitis C using different types of interferonHubmann, R. / Berg, J. / Biesenbach, G. / Raml, A. / Schmekal, B. et al. | 2002
- 112
-
What can be done for patients with chronic hepatitis C, which have failed to respond to interferon monotherapy?Iacob, R. / Iacob, S. / Diculescu, M. et al. | 2002
- 112
-
Clinical significance of mixed cryoglobulinemia in chronic hepatitis C patientsAprosina, Z. / Muchin, N. / Kozlovskaya, L. / Ignatova, T. et al. | 2002
- 112
-
Pegylated 40KDA IFN alfa-2a plus amantadine (AMA) or ribavirin (RBV) in naives with chronic hepatitis C (CHC): the HIMPCT (Hepatitis Italian Multicenter Pegasys Amantadine Cooperative Trial)Ideo, G. / Angelico, M. / Chirianni, A. / Craxi, A. / Di Perri, G. / Minoli, L. / Montalto, G. / Picciotto, A. / Rizzetto, M. / Ruggiero, G. et al. | 2002
- 112
-
The long-term outcome of liver transplant recipients with de novo hepatitis B infection who received an anti-HBC graftCauduro, S. / Douglas, D. / Rakela, J. / Dickson, R. / Wiesner, R. / Rosen, C. / Krom, R. / Ishitani, M. et al. | 2002
- 113
-
High dose induction therapy with consensus interferon and ribavirin for treatment-naive patients with hepatitis CKaiser, S. / Kreysel, C. / Hass, H. / Gregor, M. et al. | 2002
- 113
-
Primary IFN-resistance in chronic hepatitis C virus genotype 4 infectionJessner, W. / Gschwantler, M. / Watkins-Riedel, T. / Steindl-Munda, P. / Mueller, C. / Hofmann, H. / Ferenci, P. et al. | 2002
- 113
-
Changes in lipid metabolism in chronic hepatitis CJarmay, K. / Karacsony, G. / Nagy, I. / Lonovics, J. / Schaff, Z. et al. | 2002
- 113
-
Association of hypoglycemia and PEG-interferon in HCVLi, J. / Cubbedge, L. / Foster, K. / Lambiase, L. et al. | 2002
- 114
-
Comparison of peripheral blood lymphocyte subtypes in renal transplant patients with or without hepatitis C infectionSezis, M. / Ersoz, G. / Toz, H. / Karasu, Z. / Kokuludag, A. / Ok, E. / Celebi, A. / Akarca, U. / Terzioglu, E. et al. | 2002
- 114
-
Clinical and virological aspects of hepatitis B genotype B and C-infected blood donorsJia-Horng, K. / Pei-Jer, C. / Ming-Yang, L. / Ding-Shinn, C. et al. | 2002
- 114
-
Platelets hemostasis in chronic viral liver diseases during interferon treatmentKoroy, P. / Yagoda, A. et al. | 2002
- 114
-
Hematological changes during IFN/ribavirin combination therapy in patients with chronic hepatitis CWichlas, M. / Hofer, H. / Homoncik, M. / Gangl, A. / Ferenci, P. / Peck-Radosavljevic, M. / Kreil, A. et al. | 2002
- 115
-
Long-term outcome of hepatitis B in lamivudine-resistant cirrhotic patientsLampertico, P. / Vigano, M. / Romeo, R. / Iavarone, M. / Del Ninno, E. / Colombo, M. et al. | 2002
- 115
-
Second-phase viral clearance as a measure for dose optimization of anti-HBV nucleosidesLai, C. L. / Zhou, X. J. / Brown, N. / Myers, M. / Lloyd, D. / Lim, S. G. et al. | 2002
- 115
-
Serum laminin-2 and hyaluronan predict advanced liver fibrosis in children with chronic hepatitis BLebensztein, D. M. / Kaczmarski, M. / Sobaniec-Lotowska, M. / Voelker, M. / Schuppan, D. et al. | 2002
- 115
-
Serum fibrosis markers may be more sensitive to predict an antifibrotic effect of interferon alpha in children with chronic hepatitis BLebensztein, D. M. / Kaczmarski, M. / Sobaniec-Lotowska, M. / Voelker, M. / Schuppan, D. et al. | 2002
- 116
-
Genotype mixtures of hepatitis B virus in patients treated with interferonHannoun, C. / Lindh, M. / Krogsgaard, K. et al. | 2002
- 116
-
Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinomaDe Mitri, M. S. / Morsica, G. / Cassini, R. / Bagaglio, S. / Zoli, M. / Alberti, A. / Bernardi, M. et al. | 2002
- 116
-
Non-invasive grading of hepatitis C related liver disease: microbubble-enhanced ultrasound studiesLim, A. / Patel, N. / Hamilton, G. / Blomley, M. / Cosgrove, D. / Foster, G. / Goldin, R. / Thomas, H. / Taylor-Robinson, S. et al. | 2002
- 116
-
Low risk of vertical hepatitis C virus (HCV) infection in a large cohort of human immunodeficiency virus (HIV)-seronegative pregnant womenLosa, M. / Saez, A. / Lo Iacono, O. / Lozano, C. / Garcia-Monzon, C. et al. | 2002
- 116
-
Evaluation of liver fibrosis by combined serum markers in chronic hepatitis C patients treated by interferon alpha and ribavrinLeroy, V. / Trocme, C. / Bottari, S. / Sturm, N. / Morel, F. / Zarski, J. P. et al. | 2002
- 117
-
A 3-ARM randomized study evaluating the efficacy of triple therapy of pegylated or recombinant interferon alpha-2a 3 MU both combined with ribavirin and amantadine versus dual therapy of recombinant interferon alpha-2a plus ribavirin in naive patients with chronic HCV hepatitisMangia, A. / Ricci, G. / Minerva, N. / Persico, M. / Carretta, V. / Bacca, D. / Vinelli, F. / Sogari, G. / Guadagnino, V. / Maio, G. et al. | 2002
- 117
-
Study of serological markers of HBV in postransfusional hepatitis CArranz, M. D. / Del Campo Terron, S. / Garcia, J. M. / Marugan, R. B. et al. | 2002
- 117
-
Mutations in X region have little impact on response to interferon therapy for chronic hepatitis BHannoun, C. / Krogsgaard, K. / Horal, P. / Lindh, M. et al. | 2002
- 117
-
IL-10 ATA haplotype and 1st interon IFN-gamma polymorphisms are more frequent in pts with spontaneous HCV clearanceMangia, A. / Santoro, R. / D'Apolito, O. / Lacobellis, A. / Andruilli, A. et al. | 2002
- 118
-
Relationship between viral replication and fibrosis/necroinflammatory activity index in the liver is observed in chronic hepatitis B HBeAg negative but not in HBeAg positiveRezende, R. E. / Ramalho, L. N. / Zucoloto, S. / Figueiredo, J. F. / Passos, A. D. / Villanova, M. G. / Martinelli, A. L. et al. | 2002
- 118
-
Hepatitis C virus RNA in patients with HIV infectionBonacini, M. / Louie, S. / Hollinger, B. et al. | 2002
- 118
-
Relationship between the population of hepatic stellate cells (HSC) and liver iron deposit in chronic hepatitis CMartinelli, A. L. / Ramalho, L. N. / Zucoloto, S. et al. | 2002
- 119
-
The significance of hepatic steatosis (HS) in chronic hepatitis B and CKryczka, W. / Urbaniak, A. / Chrapek, M. / Michaluk, D. / Paluch, K. et al. | 2002
- 119
-
Ten-year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearanceMazzeo, C. / Azzaroli, F. / Giovanelli, S. / Dormi, A. / Festi, D. / Colecchia, A. / Miracolo, A. / Natale, P. / Nigro, G. / Alberti, A. et al. | 2002
- 119
-
Does normal ALT exclude severe hepatic fibrosis in chronic HCV patients?Metwally, M. / Zein, C. / Zein, N. et al. | 2002
- 119
-
Epidemiology and time trend of hepatitis B: a French population based studyMinello, A. / Fein, F. / Beurton, I. / Evrard, P. / Rassiat, E. / Milan, C. / Jooste, V. / Faivre, J. / Bonithon-Kopp, C. / Miguet, J. P. et al. | 2002
- 120
-
Effect of anti - retroviral therapy on liver-related mortality in HIV/HCV coinfected patientsQurishi, N. / Kreuzberg, C. / Voigt, E. / Hess, L. / Effenberger, W. / Luechters, G. / Kupfer, B. / Sauerbruch, T. / Rockstroh, K. J. / Spengler, U. et al. | 2002
- 120
-
Prospective, randomised, controlled study of the efficacy of interferon alpha-2b (IFN) plus ribavirin (RIB) in patients with chronic hepatitis C (CHC) `non responders` to IFNMoreno-Otero, R. et al. | 2002
- 120
-
Epidemiological features of new detected cases of hepatitis C and source of diagnosis in a French general populationMonnet, E. / Le Calvez, S. / Minello, A. / Jooste, V. / Obert-Clerc, B. / Beurton-Chataignier, I. / Evrard, P. / Miguet, J. P. / Hillon, P. / Bresson-Hadni, S. et al. | 2002
- 121
-
DITTO-HCV early viral kinetics report - novel decline patterns in gen 1 but not gen 2-3 patients treated with PEG-interferon-alfa-2a and ribavirinNeumann, A. U. / Zeuzem, S. / Ferrari, C. / Lurie, Y. / Negro, F. / Germanidis, G. / Esteban, J. / Hellstrand, K. / Pellegrin, B. / Soulier, A. et al. | 2002
- 121
-
Long-term HBV kinetics classification during treatment with adefovir dipivoxilNeumann, A. / Havlin, Y. / Tal, R. / Tsiang, M. / Wulfsohn, M. / Brosgart, C. / Fry, J. / Gibbs, C. et al. | 2002
- 121
-
Lamivudine retreatment of pts who have relapsed after a previous course of lamivudine with or without interferonNiro, G. A. / Palmieri, O. / Facciorusso, D. / Piermanni, V. / Andriulli, A. et al. | 2002
- 121
-
Predictors of progression of liver disease in chronic hepatitis C patients with minimal fibrosis: kinetic of serum tumor necrosis factor and transforming growth factor serum levelsNeuman, M. / Malkiewicz, I. / Benhamou, J. P. / Valla, D. / Martinot-Peignoux, M. / Akremi, R. / Asselah, T. / Marcellin, P. et al. | 2002
- 122
-
Cardiovascular effects of canrenone in pre-ascitic cirrhosisPantaleo, P. / La Villa, G. / Barletta, G. / Romanelli, R. G. / Del Bene, R. / Laffi, G. / Gentilini, P. et al. | 2002
- 122
-
Baseline alt predicts histologic and serologic response in patients with HBeAg+ chronic hepatitis B treated with adefovir dipivoxil (ADV)Marcellin, P. / Chang, T. T. / Lim, S. G. / Tong, M. / Sievert, W. / Shiffman, M. / Jeffers, L. / Goodman, Z. / Chen, S. / Jain, A. et al. | 2002
- 122
-
Characteristics and outcome of biochemical breakthroughs (BBTS) in patients with HBeAg-negative HBV related chronic liver disease [HBeAg(-)CLD] under long-term lamivudine monotherapy (LAM)Papatheodoridis, G. / Dimou, E. / Laras, A. / Papadimitropoulos, V. / Hadziyannis, S. et al. | 2002
- 122
-
Entecavir significantly reduces viral load in liver transplant recipients failing lamivudine therapy for chronic hepatitis B infectionShakil, A. O. / Lilly, L. / Angus, P. / Gerken, G. / Thomas, N. / Jean, M. / Joshi, S. et al. | 2002
- 123
-
The liver is the main site for metabolism of circulating advanced glycation end productsHoriuchi, S. et al. | 2002
- 123
-
Clinical significance of HCV core antigen, a new marker of HCV infectionBouvier-Alias, M. / Patel, K. / Dahari, H. / Beaucourt, S. / Larderie, P. / Blatt, L. / Hezode, C. / Dhumeaux, D. / Neumann, A. / McHutchison, J. et al. | 2002
- 123
-
Utility of systematic HCV RNA testing in organ and tissue donors to improve transplantation viral safetyChalline, D. / Laperche, L. / Rigot, P. / Larderie, P. / Guerrini, P. / Gerota, J. / Sabatier, P. / Pawlotsky, J. M. et al. | 2002
- 123
-
Dynamics of lamivudine-resistant HBV mutants: a quasispecies analysisPallier, C. / Castera, L. / Soulier, A. / Dhumeaux, D. / Metreau, J. M. / Pawlotsky, J. M. et al. | 2002
- 124
-
Immunomodulatory properties of pegylated interferons: the 40 kD pegylated IFN alfa 2a has greater Th1 stimulatory activity than the 12 kD pegylated IFN alfa 2bPlatis, D. / Germain, C. / Lombardi, G. / Foster, G. et al. | 2002
- 124
-
New strategy of lamivudine treatment in HBV-related chronic hepatitis: a pilot studyPersico, M. / De Marino, F. A. / Persico, E. / Di Giacomo Russo, G. / Morante, A. / La Mura, V. / Palmentieri, B. / Torella, R. et al. | 2002
- 124
-
Diagnostic use of the Cobas HBV-PCR test in HBs Ag positive and HBV-DNA negative patients by standard hybridizationPichard, A. V. / Chaix, M. L. / Lagneau, J. L. / Nalpas, B. / Brechot, C. / Pol, S. et al. | 2002
- 124
-
Gender differences in HCV viral load among methadone-maintained patientsPiccolo, P. / Bart, G. / Borg, L. / Handy, S. / Ho, A. / Zhang, L. / Kreek, M. J. et al. | 2002
- 125
-
Biochemical and virological response in HBsAg and anti-HBe positive patients treated with interferon alfa and Famciclovir for 6 monthsSentiens, R. / Beld, M. / Rebers, S. / Reesink, H. et al. | 2002
- 125
-
Performance of the prototype diagnostic HCV antigen test and comparison with the HCV 3.0 bDNA assay in patients treated with high dose interferonSentjens, R. / Beld, M. / Rebers, S. / Verhoeven, G. / Lee, S. et al. | 2002
- 125
-
Absence of long term relapse in patients with a good virological response at 6 months after treatment for chronic hepatitis CArlettaz, P. P. / Blanc, P. / Pageaux, G. P. / Ramos, J. / Ducos, J. / Larrey, D. et al. | 2002
- 125
-
Open-label study of omega interferon in previously untreated HCV-infected patientsPlauth, M. M. / Meisel, H. / Langecker, P. / Moran, M. / Lang, W. / Blanchett, D. / Jetschmann, J. U. / Brack, J. / von Wussow, P. et al. | 2002
- 126
-
Role of leptin and hepatic stellate cell (HSC) in the development of steatosis in chronic hepatitis CCastellano-Megias, V. M. / Alcon, J. C. / Cruz, M. / Irles, J. A. / Vazquez, T. / De La Cruz, C. / Robles, A. / Romero-Gomez, M. et al. | 2002
- 126
-
HGV/GBV-C transmission by blood components in patients undergoing open-heart surgerySentjens, R. / Simmonds, P. / Basaras, M. / Vrielink, H. / Reesink, H. et al. | 2002
- 126
-
Rapid HCV RNA decline after daily 18 MU interferon induction combined with ribavirin and amantadine in chronic HCV patientsSentjens, R. / Beld, M. / Weegink, C. / Rebers, S. / Reesink, H. et al. | 2002
- 126
-
Nramp1, Nramp2 AND TfR2 gene alterations in iron overload in chronic hepatitis C (CHC)Sanchez, D. / Romero-Gomez, J. M. / Gonzalez-Escribano, F. / Montes, M. / Castellano-Megias, V. M. / Gomez, L. / Alcon, J. C. / Robles, A. / Nunez-Roldan, A. / Grande, L. et al. | 2002
- 126
-
Antibodies and primary biliary cirrhosis - piecing together the jigsawNeuberger, J. et al. | 2002
- 127
-
Ophthalmopathy due to treatment with pegylated alpha interferon in patients with chronic hepatitis CSahm, S. / Will, R. / Schlegel, A. / Bruening, A. et al. | 2002
- 127
-
New sensitive assays for the study of the clinical relevance of HBV genomic variationSablon, E. / De Gendt, S. / Doutreloigne, J. / Juras, J. / Van Assche, E. / Van Brussel, M. / Van Overbeke, M. / Maertens, G. et al. | 2002
- 127
-
HBV subtype as significant marker in the clinical course of chronic HBV infection in JapanSakai, T. / Shiraki, K. / Inoue, H. / Okano, H. / Yamanaka, T. / Deguchi, M. / Ohmori, S. / Sugimoto, K. / Murata, K. / Fujioka, H. et al. | 2002
- 127
-
Lamivudine-resistant HBV mutants in patients with anti-HBe positive chronic hepatitis B treated with long-term lamivudine monotherapySantantonio, T. / Sinisi, E. / Insalata, M. / Palumbo, E. / Guastadisegni, A. / Pastore, G. et al. | 2002
- 128
-
Qualitative and quantitative platelet abnormalities in hepatitis C virus associated chronic liver diseaseGoubran, F. / Serwah, A. H. / Abdel-Hamid, A. / El-Gohary, A. / Wissa, N. / Fahmyl, H. / Younis, S. et al. | 2002
- 128
-
Interferon alone versus interferon plus ribavirin in the treatment of patients with acute hepatitis C: a pilot studySantantonio, T. / Sinisi, E. / Guastadisegni, A. / Palumbo, E. / Pastore, G. et al. | 2002
- 128
-
Prolonged lamivudine treatment in patients with chroni active anti-HBe positive hepatitisFazio, V. / Angarano, G. / Scotto, G. et al. | 2002
- 128
-
Effect of combined lamivudine and interferon alpha treatment on the T-cell response to HBV core peptides in patients with chronic hepatitis B virus infectionCavers, M. / Aw, M. / Sharma, U. / D'Antiga, L. / William, R. / Moorat, A. / Greensmith, M. / Atkins, M. / Mieli-Vergani, G. / Vergani, D. et al. | 2002
- 129
-
Ribavirin/interferon alpha-2b therapy is very effective in the treatment of chronic hepatitis C genotype 2 & 3 patients who have failed to respond virologically to interferon monotherapyPimstone, N. / Sheykhzadeh, P. / Canio, J. / Chiang, M. / Powell, J. / Kokosinski, J. / Saicheur, T. / Yu, A. et al. | 2002
- 129
-
Efficacy of pegylated (40 KDA) IFN alfa-2a (PEGASYS) plus ribavirin in the treatment of hepatitis C genotype 4 chronic active patients in Saudi ArabiaShobokshi, O. / Serebour, F. / Skakni, L. / Tantawi, A. / Dinish, T. / Al Quaiz, M. / Sandokji, A. / Al-Kayyal, B. / Al Momen, S. / Akbar, H. et al. | 2002
- 129
-
Cost-effectiveness of peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis CSiebert, U. / Sroczynski, G. / Rossol, S. / Wasem, J. / Ravens-Sieberer, U. / Kurth, B. M. / Manns, M. P. / Hutchison, J. G. / Wong, J. B. et al. | 2002
- 129
-
Interferon alone or in combination with ribavirin for the treatment of chronic hepatitis C genotype IVShiha, G. / Salem, S. et al. | 2002
- 130
-
Does health-related quality of life reflect disease severity in chronic hepatitis C patients?Siebert, U. / Ravens-Sieberer, U. / Greiner, W. / Sroczynski, G. / Wong, J. B. / Kuntz, K. M. / Kallinowski, B. / von der Schulenburg, J. M. / Bullinger, M. / Rossol, S. et al. | 2002
- 130
-
Untypical forms of hepatitis ASikorska, K. / Radowska, D. / Swiderska, M. / Malanowicz-Swierczynska, K. et al. | 2002
- 130
-
Quantitation of HCV viremia in patients with chronic hepatitis assessed by second and third generation branched DNASoffredini, R. / Rumi, M. / Russo, A. / Colombo, M. et al. | 2002
- 130
-
Transplantation for alcoholic liver diseaseNeuberger, J. / Schulz, K. H. / Day, C. / Fleig, W. / Berlakovich, G. A. / Berenguer, M. / Pageaux, G. P. / Lucey, M. / Horsmans, Y. / Burroughs, A. et al. | 2002
- 131
-
Simple and reliable method for HCV-RNA detection/genotyping in dried blood spotsSolmone, M. / Girardi, E. / Costa, F. / Ippolito, G. / Capobianchi, M. et al. | 2002
- 131
-
Characteristics and outcome of antiHCV positive serum HCV RNA negative patientsGaleras, J. A. / Rivera, M. / Coll, S. / Barranco, C. / Gimenez, M. D. / Ezquerra, Y. / Bory, F. / Vila, M. C. / Sola, R. et al. | 2002
- 131
-
Fatty liver (FL) in chronic hepatitis B carriers may affect the interpretation of alanine aminotransferase (ALT) elevationsSoon, D. K. / Pan, A. X. / Yeo, S. H. / Ho, L. H. / Wise, S. D. et al. | 2002
- 131
-
Low ferritin levels and body mass index are independent predictors of persitently normal alt levels in HCV RNA positive subjectsMinola, E. / Maggiolo, F. / Fracassetti, O. / Ravasio, V. / Suter, F. / Casagrande, F. / Strazzabosco, M. et al. | 2002
- 132
-
Long term use of adefovir in HIV-HBV coinfected patients is not associated with emergence of specific HBV polymerase mutationsThibault, V. / Benhamou, Y. / Bochet, M. / Kalkias, L. / Xiong, S. / Brosgart, C. et al. | 2002
- 132
-
Quantitative HBV-DNA testing: are we ready for international units?Thibault, V. / Roy, M. / Boutonnet, V. / Benhamou, Y. / Bochet, M. / Agut, H. et al. | 2002
- 132
-
Randomized, controlled trial with interferon-alpha plus ribavirin with and without amantadine sulphate in patients with chronic hepatitis C relapsing after previous successful antiviral treatmentTeuber, G. / Pascu, M. / Lafrenz, M. / Weidenbach, H. / Schoelmrich, J. / Wietzke-Braun, P. / Arnold, R. / Pausch, J. / Lock, G. / Zeuzem, S. et al. | 2002
- 132
-
Modeling the hepatitis C virus epidemic in Greece: implications for the future hepatitis C morbidity and mortalitySypsa, V. / Touloumi, G. / Hatzakis, A. et al. | 2002
- 133
-
Dynamics of response to interferon (IFN) plus ribavirin (RIB) in chronichepatitis C (CHC) patientsMarugan, M. T. / Monteagudo, J. A. / Buey, L. G. / Borque, M. J. / Otero, R. M. et al. | 2002
- 133
-
Use of Inno-Lipa HBV-DR to assess the sensitivity of lamivudine-resistant HBV mutants to adefovirThibault, V. / Benhamou, Y. / Lada, O. / Mousnier, F. / Bochet, M. / Xiong, S. / Brosgart, C. / Sablon, E. et al. | 2002
- 133
-
Longitudinal characterisation of pre-core and reverse transcriptase HBV mutants in OLT patients treated with lamivudine or lamivudine plus FamciclovirTorre, F. / Graziadei, I. / Delfino, A. / Vogel, W. / Picciotto, A. et al. | 2002
- 133
-
Relevance of total HCV core antigen testing for monitoring and predicting patients responseMaynard, M. / Berthillon, P. / Pradat, P. / Martinot, M. / Marcellin, P. / Trepo, C. et al. | 2002